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Abstract 
 
Background: Chronic wounds effect millions of people globally.  It is a debilitating condition 
that diminishes health related quality of life.  Wound bed preparation is necessary for wound 
healing.  In order for some wounds to heal, debridement plays an important role.  Larvae 
therapy is one form of debridement, which will be the main focus of this systematic review. 
Aim & Objectives: To explore the literature pertaining to the use of larvae therapy in chronic 
wounds to determine its impact on debridement. 
Selection Criteria: This systematic review included studies in English, randomised control 
trials, clinical control trials, comparative studies, retrospective studies, prospective studies and 
systematic reviews.  The chronic wounds included in the review were pressure ulcers, diabetic 
foot ulcers and leg ulcers. 
Data Collection & Analysis: Studies that fit the inclusion criteria were included in this review.  
Data analysis were completed in narrative form.  The PRISMA statement was used for 
synthesising the systematic review included in this study. 
Main Results: After completing a systematic research of the literature, 14 studies were 
included in this review.  The main primary outcome was rate of debridement of a chronic 
wound.  Secondary outcomes included healing rate, pain, health related quality of life and 
acceptability of larvae therapy. 
Conclusion: The overall results show that larvae debridement therapy is an effective, safe and 
fast method of debridement in chronic wounds.  
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Chapter1: Introduction & Background 
 
1.1 Introduction 
This chapter will give an overview of the statistics of chronic wounds.  It will then discuss the 
importance of wound bed preparation and the role debridement plays.  Larvae therapy will be 
discussed, including its role in debridement, how it works and patient and staff perceptions 
towards larvae therapy. 
 
1.2 Prevalence & Incidence of Chronic Wounds 
A chronic wound is defined as an open wound that has failed to heal for more than six weeks, 
common non-healing wounds include e.g. pressure ulcer, diabetic foot ulcer and leg ulcers 
(Bale & Jones, 1997).  It is estimated that six and a half million people in the USA are affected 
by chronic wounds (Sen et al 2009).  Conversely, in Europe the prevalence figures vary from 
different countries.  For example, Lindholm et al (1999) from their Swedish study, derived a 
point prevalence of chronic wounds of 2.4 per 1000 people.  Whereas, Drew et al (2007) and 
Vowden et al (2009) concluded from their studies in the UK that the point prevalence rates 
varied from 3.7 to 3.55 patients per 1000 people.  In Ireland there are very little studies on 
chronic wounds as a whole; however, a point prevalence study of pressure ulcers conducted in 
three Irish teaching hospitals noted figures of 18.5% in six hundred and seventy-two adult 
patients (Gallagher et al 2008).  Clarke-Moloney et al (2006) conducted a study in the mid-
western region of Ireland which showed a prevalence rate of 0.12% but interestingly that figure 
rose to 1.2% in the population ages over seventy years.  McDermott-Scales et al (2009) 
compiled a prevalence study set in an Irish community setting, their study showed there was a 
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4% (76/1854) point prevalence rate of pressure ulcers and 2.9% (55/1854) point prevalence 
rate of leg ulcers. 
 
1.3 Cost & Impact of Chronic Wounds 
The cost of chronic wounds is poorly documented, as the figures generally get lost amongst 
other figures for example the number of nursing hours or number of hospital admission days.  
This is as a result of the complications of wound management (Hurd, 2013).  It is estimated 
that chronic wounds cost the Unites States $25 billion annually and that this figure is rapidly 
increasing due to an increase in diabetes and obesity, an aging population and an overall 
increase in health care costs (Sen et al 2009).  Drew et al (2007) estimated that chronic wounds 
cost the UK £2.5 to £3.1 million per 100,000 people annually.  Similarly, Vowden et al (2009) 
concluded that chronic wounds cost the UK in the region of £2.03 per 100,000 people.  In 
Ireland it was estimated the cost of pressure ulcers cost the state €250 million per annum 
(Gethin et al 2005).  The cost of diabetic foot ulceration of thirty patients, in an acute Irish 
hospital was estimated at €705,000 and €23,500 per patient (Smith et al 2004).  Therefore, any 
therapy that reduces treatment time will produce a considerable cost benefit (Thomas, 2006). 
 
1.4 Quality of Life 
Chronic wounds are a complex chronic disorder that have many negative implications for the 
patient, therefore, it is necessary that patients are treated with a multidisciplinary approach that 
includes a process to optimise health related quality of life as much as possible (Hurd, 2013).  
From a human perspective, living with a chronic wound has a major impact on an individual’s 
health related quality of life.  Chronic wounds are a burden on the patient, family and on health 
care organisations; they cause pain, infection, suffering, depression, loss of independence, 
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personal functioning and they are expensive to finance (Hurd, 2013).  Pain is a major 
implication of a chronic wound which has a negative impact on day to day living (Rich & 
McLachlan, 2003).   
 
Franks et al (2003) complied a study where the quality of life of individuals living with leg 
ulceration was examined.  One hundred and eighteen patients with an average age of seventy-
eight years were included in the study.  The patients completed the Medical Outcomes Short 
Form-36 questionnaire at baseline and after twelve weeks of receiving standard treatment for 
their leg ulcer.  The results showed that patients had low mean scores in the various categories; 
physical (p=0.001), bodily pain (p=0.001), functioning (p=0.001) and social functioning 
(p=0.001).  The results did not vary much between baseline and twelve weeks.  The only 
noticeable difference was in the thirty-one patients whose ulcers healed; their overall health 
related quality of life had improved greatly, pain (p=0.003), physical (p=0.06) and mental 
health (p=0.013). 
 
Franks and Moffatt (2001) enrolled three hundred and eighty-three patients into their study. 
They used the Nottingham health profile to assess their health related quality of life while living 
with a venous leg ulcer.  Franks and Moffatt (2001) compared their results with a previous 
study that had used the Medical Outcome Short form-36 questionnaire.  The Nottingham health 
profile was used at baseline and at twelve weeks.  After twelve weeks 37% of patients’ ulcers 
were completely healed.  In all the categories of the Nottingham health profile for all three 
hundred and eighty-three patients, there was a significant improvement due to ulcer treatment 
(p=0.01).  This study show that at baseline patients’ quality of life was poorer due to the leg 
ulcer. 
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Shukla et al (2008) carried out a one day study on how people lived with chronic wounds in 
India.  Fifty patients were included in the study.  The patients were given a questionnaire to 
complete.  The overall results showed that patients were not satisfied with their health related 
quality of life with regards to general activities (56%), physical activities (54%), social 
relations (54%), leisure activities (64%) and household activities (52.6%).  Not surprisingly, 
the size of the wound impacted on quality of life.  The patients with larger wound were less 
satisfied with household duties, physical activity, social activities and feelings. 
 
Hurd (2013) states that professionals in the health care system and indeed society do not 
understand the full complexities and burden that individuals living with a chronic wound have 
to bear.  International consensus suggested that health care professionals need to look past the 
patient and see the person behind the chronic wound and understand how that chronic wound 
impacts that individual in their everyday life (Hurd, 2013). 
 
1.5 Wound Bed Preparation 
For a wound to heal it involves a four stage process 
• Coagulation 
• Inflammation 
• Cell proliferation and repair of the matrix 
• Epithelialization and remodelling of the scar tissue (Schultz et al 2003). 
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In a chronic wound this process becomes stationary or fixed at one or more of the various stages 
of healing (Schultz et al 2003).  Indeed, chronic wounds have complicated features and may 
produce large amounts of exudate which impair the wound healing process (Schultz et al 2003).  
Wound bed preparation (WBP), therefore, plays an important role in wound healing (Schultz 
et al 2003).  WBP is defined as the management of a wound in order to facilitate healing so 
that further treatments can be initiated. It involves management of exudate, correcting the 
imbalance of bacteria and continuous debridement (Schultz et al 2003).  The TIME acronym 
was devised by Schultz et al (2003) to assist with implementing correct WBP.  TIME is an 
acronym for the following: 
 
• Tissue management 
• Infection or inflammation 
• Moisture balance 
• Epithelial edge. 
 
The aim of TIME is to identify barriers to wound healing and to implement a plan to promote 
wound healing (Schultz et al 2003). 
Debridement plays an important role in the management of chronic wounds.  Often, the 
pathophysiology process within the chronic wound causes the wound to have a continuous 
accumulation of necrotic and unhealthy tissue.  Therefore frequent debridement is necessary in 
order to facilitate the natural wound healing process.  Debridement also helps to reduce the 
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bacterial load in a chronic wound which in turn will assist the wound to return to the normal 
healing process (Schultz et al 2003). 
 
1.6 Debridement 
The European Wound Management Association (EWMA) (2013) defines debridement as 
“the act of removing necrotic material, eschar, devitalised tissue, serocrusts, infected 
tissue, hyperkertosis, slough, pus, haematomas, foreign bodies, debris, bone fragments 
or any other type of bioburden from a wound with the objective to promote wound 
healing”(Pg. s4). 
 
There are various forms of wound debridement:  
• Autolytic debridement 
• Surgical/Sharp debridement 
• Enzymatic debridement 
• Mechanical debridement 
• Larvae therapy debridement 
 (Schultz et al 2003). 
 
Autolytic debridement: This process can occur automatically in some wounds. It occurs when 
macrophages and proteolytic enzymes separate necrotic and sloughy tissue from healthy tissue.  
Dressings like hydrocolloids and hydrogels can enhance this process by enhancing the activity 
of phagocytic cells (Schultz et al 2003). 
 
17 
 
Surgical/Sharp debridement: This is the quickest method of debridement.  The blade used for 
debridement removes dead and sloughy tissue and also reduces the bacterial load in the wound 
bed (Schultz et al 2003) 
 
Enzymatic debridement: This is where various enzymes are applied to the wound surface and 
debride the sloughy necrotic tissue (Schultz et al 2003). 
 
Mechanical debridement: This involves wound irrigation and wet-to-dry dressing techniques 
(Schultz et al 2003. 
 
Larvae debridement therapy (also known as maggot debridement therapy) is a debridement 
method where the larvae of the Lucilia sericata fly are applied to the wound.  The larvae ingest 
and breakdown dead tissue and also decrease the bacterial load of the wound (Schultz et al 
2003). 
 
For the purpose of this systematic review this writer wishes to explore the impact larvae therapy 
has on chronic wound healing.  Therefore it is important to analyse in greater detail the 
characteristics of larvae therapy and the way in which it potentially works on chronic wounds. 
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1.6.1 Larvae Debridement Therapy 
The Lucilia sericata fly, also known as the blow fly or Phaenicia sericata fly are found 
throughout Europe (Martinez-Sanchez et al 2007).  They are the most frequently used fly 
obtained for debridement.  There are various laboratories that collect these larvae and sterilise 
them, which makes them fit for debridement purposes. 
 
Larvae debridement therapy is growing in popularity over the last number of years (Sherman, 
2009).  The effects of larvae therapy on a wound were first observed by Baron Larrey, who 
was Napoleon’s physician-in-chief and by Dr. Joseph Jones who was a doctor during the 
American Civil War (Mumcuoglu et al 1998).  These observation were medically tested first 
by Baer (1931).  Baer, who was an orthopaedic surgeon in the First World War, observed first 
hand soldier’s wounds that were infested with maggots contained healthy epithelizing tissue as 
opposed to the wounds of the soldiers that did not have maggots in them.  Baer went on to test 
his theory on osteomyelitis patients, his theory proved ground breaking and larvae debridement 
therapy became very popular. Unfortunately, during the 1940’s maggot debridement therapy’s 
popularity declined due to the introduction and availability of antibiotics (Sherman, 2009).  By 
the late 1980’s antimicrobial resistance e.g. MRSA, was commonplace and the number of 
wounds also seemed to be on the rise including pressure ulcers, leg ulcers and diabetic foot 
ulcers (Sherman, 2009).  Larvae debridement therapy has, since then, become increasingly 
popular and is considered an excellent form of debridement (Pettican & Baptista, 2012). 
 
1.6.2 How Larvae therapy works 
When larvae are placed on a chronic wound they secrete or excrete proteolytic enzymes which 
breaks down the necrosis and slough into a semi-solid substance, allowing the larvae to ingest 
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this necrotic and sloughy tissue (Fear et al 2003), this process is known as extracorporeal 
digestion (Blueman & Bousfield, 2012).  Larvae have mandibles rather than teeth, which are 
two hook like features, which enable the larvae to tear and effectively debride the unhealthy 
tissue. Furthermore, this process enables the larvae access areas of the wound that would be 
otherwise difficult to get to (Fear et al 2003).  Beasley & Hirst (2004) state that the movement 
and irritation caused by the larvae results in increased production of serous fluid which in turn 
dilutes the bacteria present.  Furthermore, the pH levels of a wound increases with larvae 
therapy due to the antibacterial secretions, thus allowing the wound bed to become an 
environment that enhances the healing process due to the elimination of bacteria (Beasley & 
Hirst, 2004).   
 
1.6.3 Application of Larvae therapy 
Larvae therapy can be applied to the wound either in loose or bagged form (EWMA, 2013).  
The loose method involves protecting the peri-wound with a hydrocolloid dressing or 
sudocrem, applying the larvae, covering it with a mesh type dressing and securing it with tape.  
The wound can then be covered with a loose secondary dressing.  Loose larvae applied to the 
wound is recommended at a dose of 10-15cm2 and should be changed every 24-72 hours 
(EWMA, 2013).  The bagged form of larvae, also called a bio-bag, are applied directly onto 
the wound bed, having protected the peri-wound.  A loose secondary dressing is then applied 
over the wound (EWMA, 2013).  In order for the larvae debridement to be efficient, it is 
important that there is sufficient exudate from the wound (EWMA, 2013).  The excess exudate 
from the wound is soaked into the loose secondary dressing. 
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1.6.4 Patient and staff perspectives of Larvae therapy 
There is a mixed view of patient and staff perceptions regarding larvae therapy.  Kitching 
(2004) carried out a phenomenological study on patient perceptions on larvae therapy.  There 
were six patients recruited to the study; initially the patients were reluctant to commence on 
larvae therapy but once they were educated and started the larvae therapy, their negative feeling 
vanished.  Steenvoorde (2005) conducted a study regarding larvae therapy; of the forty-one 
patients enrolled in the study, no one declined larvae therapy.  The results of the study show 
that 89% of the patients would agree to larvae therapy if required in the future.  Spilsbury et al 
(2008) had thirty five patients in their study on patient perspectives, of that thirty five, twenty 
seven of the participants stated they would consider larvae therapy regardless weather they 
were loose or bagged.  Dumville et al (2009) included a secondary outcome of larvae therapy 
on patient and staff perceptions in their study.  Of the eighteen patients recruited, sixteen said 
they would accept larvae therapy irrespective of the method used. Of the two patients that 
declined the larvae therapy, one of them was open to changing her mind once she learned the 
larvae were available in bagged form. 
 
Staff perceptions of larvae therapy is poorly documented, Dumville et al (2009) included staff 
perception in their study. Of the twenty two nurses in the study two nurses would not entertain 
the idea of having to handle larvae even if they were in bagged form. 
 
Steenvoorde (2005) states that by educating and proving valid information regarding larvae 
therapy, any preceded thoughts should be eliminated.  This education should be given to 
patients and healthcare workers, therefore larvae therapy can become more widely accepted as 
a form of debridement for chronic wounds. 
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1.7 Summary 
Chronic wounds are clearly a problem for many people worldwide, with 6.5 million people in 
the United States suffering alone (Sen et al 2009).  Chronic wounds are very expensive to treat, 
therefore the old proverb prevention is better than cure is applicable.  Wound bed preparation 
plays a very important factor when it comes to healing wounds.  The problem with chronic 
wounds is that they are stuck in one or more of the wound healing stages.  Therefore, in order 
for a chronic wound to heal its wound bed must be prepared correctly.  Debridement is vital to 
the initiating of assisting wounds to heal.  There are different types of debridement, autolytic 
debridement, surgical/sharp debridement, enzymatic debridement, mechanical debridement 
and larvae therapy debridement.  As the writer wishes to explore the impact larvae therapy has 
on chronic wound healing for the purpose of this systematic review, larvae therapy was 
discussed.  Larvae debridement therapy was first tested medically by Baer.  Baer discovered 
that sterile larvae were an excellent from of debridement and it became very popular.  Due to 
the discovery of antibiotics their popularity declined.  As antimicrobial resistance has been 
rising since the late 1980’s, larvae therapy is becoming an increasingly preferred method of 
treatment.  Larvae of the Lucilia sericata fly are most commonly used form of larvae for 
debridement, they work by ingesting necrotic and sloughy tissue, therefore effectively 
debriding the wound and decreasing the bacterial load of the wound. 
 
Overall patient and staff perceptions of larvae therapy are surprisingly positive.  Although more 
studies are required to examine staff perceptions. 
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1.8 Conclusion 
Chronic wounds are debilitating.  In order for these wounds to heal it is vital that these wounds 
have efficient wound bed preparation, so the patient can have a better health related quality of 
life.  Larvae debridement therapy is an effective debridement method and will be the focus of 
this systematic review. 
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Chapter 2 Methodological Issues in Systematic Reviews 
 
2.1 Introduction 
This chapter sets out to explore the various steps involved in conducting a systematic review; 
different authors state there are various amount of steps e.g. 1) Question Formulation 2) Review 
of inclusion and exclusion criteria 3) Searching the literature 4) Study selection and collecting 
data 5) Data extraction 6) Quality Appraisal 7) Data analysis and synthesis.  The writer will go 
into each of these headings in detail. The writer will also emphasise the importance of 
conducting systematic review in contributing to maintaining clinical practice as up to date as 
possible. 
 
2.2 The Concept of Systematic Reviews 
Healthcare professionals are required to and rely on the best available evidence to support their 
current practice (Akobeng 2005, Benzies et al 2006, Evans & Pearson 2001, Fineout-Overholt 
et al 2008, Mulrow 1994), so that their patients can rely on their practitioner as having the most 
up to date skills as possible.  It is important that healthcare professionals do not make important 
decisions regarding their practice based on limited studies and research (Akobeng, 2004).  As 
doing so, may have a detrimental effect on their patients if the research is not valid or properly 
supported.  Systematic reviews provide a synopsis of studies related to a particular question, 
as a precursor, rigorous searching is carried out and then the information gathered is critically 
appraised and synthesised (Fineout-Overholt et al 2008).  The data synthesised is then 
displayed as results (CRD, 2008). 
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Dr. Archie Cochrane was a British respiratory epidemiologist; he criticized the medical 
profession for not using evidence based practice in their work (Magarey, 2001).  Cochrane 
himself undertook a systematic review of RCT’s where women that were expected to deliver 
prematurely were given steroids (Watson et al 2008 & Moore 2012).  This systematic review 
showed that there was a reduction in premature births by up to 50%.  Steroids were not widely 
used in this context before Cochrane conducted his systematic review as Obstetricians did not 
know of these findings (Watson et al 2008 & Moore 2012).  As a result of this work, Cochrane 
showed the importance of carrying out a systematic review in order to obtain the best evidenced 
based information and in 1993 the Cochrane Collaboration was set up in the UK to further 
expand the conduct of systematic reviews of evidence (Watson et al 2008 & Moore 2012).  The 
Joanna Briggs Institute in Australia is another institute that is dedicated to conducting and 
publishing systematic reviews (Fineout-Overholt 2008, O’Mathuna 2010 & Magarey 2001). 
 
Systematic reviews are regarded as the highest form of evidence on hierarchies of evidence 
(McGowan, 2012).  Hierarchies of evidence rank evidence according to how valid their 
findings are (McGowan, 2012).  The Cochrane Library Glossary of Terms (2014) defines a 
systematic review as:  
“A review of a clearly formulated question that uses systematic and explicit methods to 
identify, select, and critically appraise relevant research, and to collect and analyse 
data from the studies that are included in the review. Statistical methods (meta-
analysis) may or may not be used to analyse and summarise the results of the included 
studies.” 
 
The objective of a systematic review is to allow healthcare professionals to make informed 
decisions in their area of work using the best evidence available.  The quality of the research 
determines the quality of the systematic review (Fineout-Overholt et al 2008).  Systematic 
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reviews attempt to minimise bias whereas a literature review has the potential to be full of bias, 
weather intentional or not (O’Mathuna, 2010).  This is because traditional literature reviews do 
not have a strategic research process, they do not analyse and synthesise data in a systematic 
way nor do they usually conduct a rigorous quality appraisal on the studies researched 
(Magarey 2001).  Furthermore, literature reviews have a tendency not to deal with conflicting 
studies as the author has the choice of which studies they wish to include, which leads to a 
further source of bias (Callcut & Branson, 2009).  A further issue is that some literature reviews 
are written by experts in their field and as they would have an obvious interest in the particular 
area bias is inevitable (Callcut & Branson, 2009).  However, the main difference between a 
systematic review and a literature review is that in a systematic review rigorous steps in the 
conduct of the review are closely adhere to. These steps are aimed to reduce bias (Fineout-
Overholt et al 2008). 
 
2.3 Steps in a Systematic Review 
Different steps to be undertaken when conducting a systematic review have been described 
(CRD, 2008).  For example the Centre for Reviews and Dissemination (CRD) (2008) outline 
nine steps, whereas the Cochrane Collaboration outline eight steps (Higgins & Green, 2011).  
In addition, Fineout-Overholt et al (2008) and Magarey (2001) outline seven steps whereas 
Windle (2010) and Khan et al (2003) outline just five steps.  When these steps are brought 
together the following steps appear common to all: 
 
• Question Formulation 
• Review of inclusion and exclusion criteria 
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• Searching the literature 
• Study selection and collecting data 
• Data extraction 
• Quality Appraisal 
• Data analysis and synthesis (CRD 2008, Higgins & Green 2011, Fineout-Overholt et al 
2008, Magarey 2001, Windle 2010 and Khan et al 2003). 
 
2.3.1 Question Formulation 
The question that the systematic review aims to answer should be clear and concise, as the 
answers provided will aim to influence clinical decision making.  If the question is too broad 
then the author runs the risk of ‘drowning’ in the literature (CRD, 2008).  It is also important 
to include background information of the systematic review; it should include why the review 
is required and also information to ensure the reader is informed about the topic at hand.  An 
example of a systematic review that includes background information is entitled ‘Risk 
assessment tools for the prevention of pressure ulcers’ (Moore & Cowman, 2014).  The 
objectives of a systematic review are also important to include at this stage.  The CRD (2008) 
uses the PICO method, where P stands for population, I for intervention, C for comparison, and 
O for outcomes.  This method guides the author and assists them to answer their specific 
research question (CRD, 2008).  For example, Yan et al (2010) used the P.I.C.O. method in 
their review. 
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2.3.2 Review of Inclusion & Exclusion Criteria 
The inclusion and exclusion criteria should be clearly identified, so as the author knows what 
information is specifically included and what is not (CRD, 2008).  This criteria should not be 
too narrow as the author will not find enough data to conduct their systematic review, on the 
other hand the criteria should not be too broad either as they will have too much information 
to analyse (CRD, 2008).  It is important that the inclusion criteria will allow for all studies of 
interest to the topic to be identified in the findings (CRD, 2008).  The systematic review entitled 
‘Comparing midwife-led and doctor-led maternity care: a systematic review of reviews’ 
(Sutcliffe et al 2012) clearly define their inclusion and exclusion criteria. 
 
2.3.3 Searching the literature 
This step is considered the most important as the quality of the systematic review is influenced 
by the relevance and inclusivity of the studies included (O’Mathuna et al 2008).  Therefore, 
the search, should be carried out with scientific rigour (Magarey, 2001).  This search should be 
described and documented in detail so if someone wished to repeat the search they would have 
no problem in doing so (O’Mathuna, 2010).  Electronic databases such as the Cumulative Index 
of Nursing and Allied Health Literature (CINAHL) and PubMed should be searched to find the 
relevant data, however the choice of search engine will depend on the subject under 
exploration.  Indeed, there are numerous different electronic databases which could be 
potentially used (CRD, 2008).  Magarey (2001) suggests that there can be problems with 
searching electronic databases.  For example, if the information on the database is poorly 
tagged all the required information may not be retrieved.  Furthermore, there may not be a 
standard search terms between the various databases, for example PubMed uses Medical 
Subject Heading (MeSH), CINAHL does not.  It is important to search different databases to 
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decrease the chance of excluding an article that may be important.  Therefore, journal and 
research articles should also be searched manually, however this may be a time staking process 
and more than one person would be required to help to manually search for studies; in addition, 
unpublished work may be included if relevant (O’Mathuna et al 2008).  As an example Moore 
& Cowman (2014) clearly outline their search strategy with a list of search terms used in their 
systematic review. 
 
2.3.4 Study Selection & Collecting Data 
Study selection can be done in two different stages (CRD, 2008).  Firstly the titles and abstracts 
of each study are read, the author then chooses studies that fit the inclusion criteria.  Of the 
studies that fit the criterion the author examines the study and includes or exclude it depending 
on the relevant criteria (CRD, 2008).  Any duplicate studies will not be included.  Precision in 
this section will ensure that the studies collected aim to answer the research question correctly 
(Magarey, 2001). Moore & Cowman (2014) and Sutcliffe et al (2012) both include a data 
selection section in their reviews. 
 
2.3.5 Data extraction 
Data extraction tools are very useful for this section (CRD, 2008). These tools outline exactly 
what information is to be extracted from each study under headings such as: 
 
• Authors & date of publication,  
• Geographical location & health care setting 
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• Study design 
• Data Collection 
• Research question aim and objective 
• Population & sample 
• Inclusion & exclusion criteria 
• Sample size calculation & randomisation sequence generation  
• Intervention 
• Patient characteristics 
• Blinding 
• Outcome measures  
• Results and conclusion. 
 
There are a wide number of different data extraction tools and these may need to be altered 
depending on the review (O’Mathuna et al 2008).  Magarey (2001) recommends that data be 
extracted by at least two people so that the risk of error is minimised.  Furthermore, White & 
Schmidt (2005) recommend that data extraction is done independently by the two data 
extractors to avoid misinterpretation of the results.  Moore & Cowman (2014) give a list of the 
headings they used for their data extraction tool, whereas Sutcliffe et al (2012) state they 
completed data extraction table but only gave an example of a few headings. 
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2.3.6 Quality Appraisal 
Although systematic reviews are considered to be at the top of the pyramid in the hierarchy of 
evidence; this does not mean that every systematic review completed is of good quality 
(Akobeng, 2005).  Glynn (2006) devised a critical appraisal checklist that assists the author to 
calculate the validity of each study.  The checklist is broken down into four sections entitled 
population, data collection, study design and results.  Within each of these four sections further 
questions are asked of the study to determine its quality.  The CRD (2008) states that quality 
appraisal should include the following:  
 
• Appropriateness of study design  
• Potential risk of bias  
• Outcome measures  
• Quality of reporting and  
• Quality of the intervention.   
 
The quality of the study in question can have an impact on the interpretation of the overall 
outcome, because if the quality of the study is poor the outcomes will not be valid or reliable 
(CRD, 2008).  The points outlined above by the CRD (2008) assist the author to ensure that 
the study is of a high quality. 
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2.3.6.1 Appropriateness of study design 
There are a number of different types of studies that could be included in a systematic review, 
for example, randomised control trials (RCT), quasi-experimental studies and observational 
studies in addition to qualitative studies.  In the Cochrane Collaboration it is mainly RCT’s and 
clinical control trials that are used to formulate systematic reviews. The data used for the Joanna 
Briggs Institute can be quantitative or qualitative research data (Joanna Briggs Library, 2014). 
 
Randomised control trials are considered the gold standard of research designs (CRD, 2008).  
A randomised control trial is an experimental trial of an intervention or treatment; it 
incorporates random allocation to the intervention/treatment group or the control group.  If the 
study is blinded, participants are randomly selected to their group and the researcher is unaware 
who is in which group.  A large sample size is usually used from various geographical locations 
and health care settings (CRD, 2008 and Goodman & Gilchrest 2013).  For example O’Connor 
et al’s (2014) study is an randomised control trial due to its methodology. In a cluster 
randomised study groups of individuals are randomised to different treatments/interventions, 
rather than single individuals.  A problem that occurs with cluster randomised trials is the 
individuals within each group may respond similarly to other individuals, which will have an 
impact on the final results (Higgins & Green, 2001).  Reavley et al’s (2014) study is a cluster 
randomised trial, nine university campus were compared to improve mental health literacy.  A 
Quasi-experimental study differs from a RCT mainly due to the way in which the participants 
are allocated to their groups.  Quasi-experimental studies do not use randomization to the study 
group, or they do not employ a control group (CRD, 2008).  Schelleman-Offermans et al’s 
(2014) study is an example of a quasi-experimental study.  An Observational study is one which 
the researcher observes behaviour without manipulating it (CRD, 2008).  Observational studies 
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explore the natural effect of intervention on health outcomes (CRD, 2008).  Observational 
studies are subjective therefore one has to be careful interpreting the results.  West et al (2014) 
study is an example of an observational study; West et al (2014) study was retrospective, 
staffing levels in an ICU were monitored to see if it had any impact on critically ill patients 
surviving or not.  A limitation of an observational study is it does not rule out selection bias. 
When undertaking a systematic review, the writer must undergo a strategic systematic search, 
so that if someone wished to repeat it, they could.  From the results of that search, studies are 
included based on the inclusion and exclusion criteria.  A narrative review is carried out of the 
included studies or meta-analysis if similar studies are found (CRD, 2008). 
 
2.3.6.2 Bias 
While bias is restricted in a systematic review it is not feasible to eliminate it entirely 
(O’Mathuna et al 2008).  Moore (2012, p2799) defines bias as a ‘consistent deviation from the 
truth’.  There are different types of bias, selection bias, performance bias, attrition bias, 
detection bias, publication bias, language bias time-lag bias, citation bias and outcome 
reporting bias (McGowan, 2012, Magarey, 2001 & Moore 2012).   
 
Selection bias is bias that relates to the method in which the participants were chosen for the 
group they were assigned to (Magarey, 2001 & McGowan, 2012).  To reduce this form of bias 
concealing of the randomization of each participant is necessary, therefore the researcher will 
not know which group the participant is in (Magarey, 2001). 
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Performance bias involves a deviation in the treatment of the subjects or participants involved 
in the review that is not part of the original review (Magarey, 2001). 
 
Attrition bias occurs when participants drop out of the study (Magarey, 2001).  These drop outs 
may cause an imbalance between the different groups in the review, therefore the reasons for 
dropping out and drop out numbers must be recorded (Magarey, 2001).  It is important to 
consider whether there was identifiable reasons for people leaving the study for example they 
have felt as though the treatment was not working, therefore important information may be lost 
about how effective an intervention is if only those who found it effective remain in the study. 
 
Detection bias refers to the overall assessment of the outcome (Magarey, 2001).  The method 
of assessment should be the same for both the treatment group and the control group (Magarey, 
2001).  In order to remove this bias it is helpful if researchers are blinded but this is not always 
possible. If differing techniques are used for control and intervention researchers could be 
motivated to find differences which may not exist in reality between the two groups. 
 
Publication bias refers to the publication of studies (McGowan, 2012).  If the study results are 
in favour of the findings the author is more likely to publish the findings than if the findings 
were negative (Moore, 2012).  The publishers may also not publish findings they do not find 
interesting or of any significance (Moore, 2012).  The same is true for certain journals who 
may think it more beneficial to publish results of studies which indicated significant findings 
i.e. treatment effectiveness. It is understandable why clinicians may be more interested in these 
type of studies but in order to practice and to be informed by high quality research, it is vital to 
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have information on non-effective interventions, details of these studies may prove valuable in 
guiding future research. 
 
Language bias occurs when certain languages are excluded from the review which could 
potentially be dismissing an important research article (McGowan, 2012 & Moore, 2012).  This 
bias reduces the opportunity for widespread dissemination of important research. There may 
also be important cultural difference in studies which may be highlighted in studies published 
in particular language, dissemination of these cultural differences is important to further 
research 
 
Time-lag bias can influence the strength of evidence for or against a specific intervention 
(Moore, 2012).  Positive results are more likely to be published before negative results, this 
can have an impact on the research literature available (Higgins & Green, 2011). 
 
Citation bias is where authors include or exclude research articles so the overall results will 
show in their favour (Moore, 2012).  This will have an overall impact on the quality of the 
systematic review.  A suitable reason must be documented for inclusion or exclusion of all 
research articles (CRD, 2008).  Only citing studies which are consistent with author’s research 
aims etc. may have the effect of giving the false impression regarding the available research 
for certain interventions and influence clinicians who are seeking to use these interventions 
which may directly impact patient care. 
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Outcome-reporting bias happens when authors do not include certain reports of outcomes of 
the study (Moore, 2012).  This will have implications towards the final results.  If authors only 
report significant findings which are support their research aims this will influence the reader 
in thinking the intervention was more effective than is true, and also valuable information with 
regard insignificant results could be excluded which may be important to investigate in terms 
of informing practice. 
 
2.3.6.3 Choice of outcome measure 
When measuring outcomes it is necessary to measure the reliability and validity of the outcome 
measure itself (CRD, 2008). For example, there are various different tools used to measure 
pain.  It is necessary that these different tools are compatible and can be compared with each 
other (CRD, 2008).  For example, in the study by Dumville et al (2009) the primary research 
question is: what is the impact of healing rates in patients with leg ulcers using larvae therapy 
versus hydrogel?  The primary outcome shows these results.  One of the secondary outcomes 
of Dumville et al (2009) study was rate of debridement.   
 
2.3.6.4 Quality of reporting 
The CRD (2008) states that some studies do not report on all items relevant to the study for 
example, allocation concealment, blinding or the choice of statistical analysis.  This does not 
mean that the quality of the overall data or methods of the study is poor, however, interpretation 
by the reviewer is challenged as there may not be all the required information.  Before starting 
the review it is important that the author decides how they will manage poor reporting within 
the included studies (CRD, 2008).  Some authors assume that if something is not reported on 
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the criteria was not met at all (CRD, 2008).  The author may not have included important results 
because they did not fit with their hypothesis therefore the review may not have all the 
information to make accurate conclusions. 
 
2.3.6.5 Quality of the intervention 
The CRD (2008) state that it is necessary to assess the quality of the intervention and how the 
intervention was administered to the study participants.  This assessment determines whether 
the intervention was used appropriately and whether the participants received the intervention 
as originally designed.  If the intervention was altered in any way it could have an effect on the 
overall results (CRD, 2008).  There needs to be a very good rationale why intervention was 
altered, otherwise there is a risk the intervention was altered to improve the results. 
 
2.4 Data analysis & Synthesis 
Data can be analysed using either qualitative or quantitative methods (Magarey, 2001).  
Quantitative data are most commonly synthesised using meta-analysis (Magarey, 2001).  If the 
method of analysis used in a particular study was different, it would not be possible to 
statistically compare it to another study that used a different method.  For example in the study 
by Sherman (2002) larvae therapy was compared to conventional treatment in pressure ulcers; 
in the study by Dumville et al (2009) larvae therapy was compared to hydrogel in leg ulcers.  
Meta-analysis is not possible between these studies because the conventional treatments and 
the type of wounds used are completely different.  Another method of synthesising quantitative 
data is in narrative from, this can be guided by the PRISMA (Preferred Reporting Items for 
Systematic reviews and Meta-Analysis) statement (Moher et al 2009).  The PRISMA statement 
is divided up in 27 item checklist (See appendix 10).  The aim of the PRISMA statement is to 
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guide authors how to improve their reporting of systematic reviews and meta-analysis (Moher 
et al 2009).  Moher et al (2009) state that the PRISMA statement can be used on other types of 
studies reported on in systematic reviews not just RCT’s.  The PRISMA statement is not 
designed to be used as a quality appraisal checklist (Moher et al 2009). 
 
Qualitative Research can be synthesised using meta-ethnography, thematic analysis or 
grounded theory (CRD, 2008).  Meta-ethnography is comparing and contrasting qualitative 
studies and synthesising this information to identify new concepts (CRD, 2008).  Thematic 
analysis is to identify recurrent themes or themes of importance e.g. healthy lifestyles (CRD, 
2008). 
 
2.4.1 Meta-Analysis 
Meta-analysis is a quantitative statistical procedure which involves bringing the information 
obtained from studies that have examined the same or related clinical problems, together 
(Egger et al 1997 & Moore, 2012).  When individual studies are brought together, the sample 
size increases, therefore the information relayed by these studies is much more powerful 
statistically when they are combined (Akobeng, 2005, Magarey, 2001, Higgins & Green, 2011, 
McGowan, 2012, Moore, 2012 & Egger et al 1997).  Higgins & Green (2011) agree that another 
reason for conducting meta-analysis is that it improves the rigor of the study.  Meta-analysis 
also allows for resolutions to be found for studies that were originally conflicting, which in 
turn may lead to a new hypotheses being drawn up (Moore, 2012 and Higgins & Green, 2011). 
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Before an author conducts meta-analysis, it is imperative that they list their objective of the 
meta-analysis (Moore, 2012).  Indeed, it is not always appropriate to conduct meta-analysis.  It 
should only be carried out when the studies are homogenous, so that like can be compared with 
like.  If the studies do not have the necessary similarities, the quality of the meta-analysis will 
be poor as the studies have no statically combined power and will not have any impact on 
clinical practice (Moore, 2012).  According to Moore (2012) there are three types of data used 
when conducting meta-analysis, time to event data, dichotomous data and continuous data 
(Moore, 2012).  Time to event data is when the outcome of interest has elapsed before the event 
has occurred (Higgins & Green, 2011).  This type of data is a regular occurrence during 
oncology studies.  Dichotomous data are data that arises from outcomes that have been divided 
into two categories, where the participants can only be in one group or the other, not both.  For 
example, a woman can only be pregnant or not pregnant (Magarey, 2001 and Moore, 2012).  
Continuous data are data that can be measured in the form of a scale and can have any numerical 
value (Higgins & Green 2011 and Moore, 2012).   
 
The most common way of visually displaying meta-analysis is on a forest plot.  This is a graph 
which shows the results in a visual display (Magarey, 2001).   
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2.5 Summary 
Systematic reviews are considered the ‘gold standard’ when it comes to research.  They are at 
the top of the hierarchy of evidence pyramid.  As it is necessary for clinicians to keep their 
practice current and up to date, systematic reviews provide them with the evidence they need 
in order to do so.   
 
Systematic reviews must follow a strict protocol to reduce the risk of bias, these include, 
question formulation, inclusion & exclusion criteria, searching the literature, study selection & 
collecting data, data extraction, quality appraisal and data analysis and synthesis.  Searching 
the literature and study selection are crucial components to a systematic review.  The studies 
found and included in the review are paramount to the overall end results. 
 
2.6 Conclusion 
This chapter discussed the importance of systematic reviews in the world of research and 
clinical practice.  Without systematic reviews the clinical profession would struggle to find the 
evidence to develop and keep their standards of practice at a high level for all their patients.  
By conducting good quality systematic reviews, the level of high ranking research continues 
to grow. 
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Chapter 3: Methods employed in the review 
 
3.1 Introduction 
The aim of this chapter is to inform of the methods that were employed in this review.  The 
objectives of the review, search strategy, quality appraisal, data analysis and synthesis will be 
discussed. 
 
3.2 Research Question 
What is the impact of larvae therapy on the debridement of chronic wounds? 
 
3.3 Objectives 
The objective of this systematic review was to explore the literature pertaining to the use of 
larvae therapy in chronic wounds to determine its impact on debridement.  For the purpose of 
this review the PICO method (CRD, 2008) was used. 
 
• Population- people with chronic wounds 
• Intervention- Larvae therapy 
• Comparison- Any other form of debridement 
• Outcome- the primary outcome for this systematic review was the rate of debridement.   
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Secondary outcomes were rate of wound healing, health related quality of life, pain and 
acceptability of larvae therapy. 
 
3.4 Criteria for inclusion of studies in the review 
This systematic review included studies in the English language, RCT’s, clinical control trials, 
comparative studies, retrospective studies, prospective studies and systematic reviews.  The 
chronic wounds included in the review were pressure ulcers, diabetic foot ulcers and leg ulcers. 
 
3.5 Search Strategy 
For this systematic review the following search terms were used: 
 
• Larvae therapy debridement/maggot therapy debridement/bio surgery 
• Pressure ulcer 
• Diabetic foot ulcer 
• Leg ulcer 
 
The databases searched were CINAHL, Cochrane library, Embase, Medline at EBSCOhost and 
Web of Science.  The only limit applied was the English language. 
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3.6 Data extraction & analysis 
For the purpose of this review the data extraction tool used was that provided by the RCSI. The 
headings on the table include,  
• Author and date of publication  
• Geographical location and health care setting  
• Design 
• Aim & objectives  
• Inclusion & exclusion criteria  
• Sample size  
• Randomisation sequence 
• Intervention 
• Data collection 
• Results  
• Conclusion  
 
3.7 Quality Appraisal 
Quality appraisal was conducted using the Glynn (2006) EBL critical appraisal checklist.  This 
checklist is divided into four sections; population, data collection, study design and results.  
Each section has multiple question regarding to that heading, that can be answered earth yes, 
no, unclear or not applicable (see appendix 8). 
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3.8 Data analysis & Synthesis 
Data was analysed and synthesised using the PRISMA statement (Moher et al 2009) under 27 
headings.  These headings were 1) Title 2) Structures summary 3) Rationale 4) Objectives 5) 
Protocol & registration 6) Eligibility criteria 7) Information sources 8) Search 9) Study 
selection 10) Data Collection process 11) Data items 12) Risk of bias in individual studies 13) 
Summary measures 14) Synthesis of results 15) Risk of bias across studies 16) Additional 
analyses 17) Study selection 18) Study characteristics 19) Risk of bias within studies 20) 
Results of individual studies 21) Synthesis of results 22) Risk of bias across studies 23) 
Additional studies analyses 24) Summary of evidence 25) Limitations 26) Conclusions 27) 
Funding (Moher et al 2009) (see appendix 10).  Data synthesis was conducted narratively as 
each study compared different interventions.  A description of each study was given, studies 
were compared in terms of methodology study design and results.  Following which 
conclusions were drawn. 
 
3.9 Summary 
This systematic review examined the impact larvae therapy has on debridement of chronic 
wounds.  The primary outcome was rate of debridement of a chronic wound.  The secondary 
outcomes were rate of healing, health related quality of life, pain and acceptability of larvae 
therapy.  The search was carried out on CINAHL, Cochrane Library, Embase, Medline at 
EBSCOhost and Web of Knowledge.  The only limitation was the English language.  Data 
extraction was undertaken using a table provided by the RCSI. Quality appraisal was conducted 
using the Glynn (2006) EBL critical appraisal checklist.  Data analysis and synthesis was 
carried out using the PRISMA statement under the 27 headings mentioned above.  Data 
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synthesis was undertaken narratively as the interventions in each study were compared 
differently.  Meta-analysis was possible for two studies. 
4.0 Conclusion 
This systematic review follows the protocol required to conduct a systematic review.  Its 
primary objective was to determine the effect larvae has on the debridement of chronic wounds.  
The necessary search strategy was carried out and the data extracted, appraised, analysed and 
synthesised. 
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Chapter 4: Findings 
 
4.1 Introduction 
This chapter will give overall results of the studies obtained from the search strategy for this 
systematic review. A general description of the studies will be given in terms of study 
population, geographical location and study settings. This will be followed by an overview of 
the quality appraisal of the included studies. A detailed description of each study will be given 
followed by an outline of the results of the primary and secondary outcome measures. Finally 
a summary and conclusion will be provided. 
 
4.2 Search Results 
For the purpose of this systematic review, the writer searched five electronic databases, 
Embase, Web of Science, CINAHAL, Medline and the Cochrane Library. A total of 460 studies 
were found (see figure 1), of the 460 studies, from reading the title and abstracts where relevant, 
377 did not fit the inclusion criteria. After reading full studies a further twenty-two studies 
were excluded, a further forty-seven studies were duplicates, which left fourteen articles to 
include in this systematic review. 
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Figure 1: Search Strategy Flow Chart Adapted from PRISMA (2009) Flow Chart 
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4.3 Excluded Studies 
The twenty-two studies that were excluded did not fit the inclusion criteria for various reasons, 
for example studies included other chronic wounds apart from pressure ulcers, diabetic foot 
ulcers and leg ulcers (see appendix 7). 
 
4.4 Included Studies 
Fourteen studies were included in the review. 
 
4.5 Description of Studies 
 
4.5.1 Study Design 
Of the included papers, there was one systematic review with meta-analysis, six studies 
compared larvae therapy to a conventional method of treatment and seven explored the impact 
of larvae using pre and post-test design. 
 
Four of the studies used a retrospective design (Mumcuoglu et al 1998, Sherman 2002, Wang 
et al 2010, Sherman, 2003), five studies were of prospective design (Sherman et al 1995, 
Courtenay et al 2000, Tantawi et al 2007, Jarczyk et al 2008 and Paul et al 2009), three were 
RCTs (Mudge et al 2014, Dumville et al 2009 & Opletalova et al 2012)  one observational 
study (Wollina et al 2002) and as mentioned previously, there was one systematic review with 
meta-analysis (Gray, 2008). 
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4.5.2 Study Population 
Of the studies included five of them included individuals with diabetic foot ulcers (Mumcuoglu 
et al 1998, Sherman, 2003, Tantawi et al 2007, Jarczyk et al 2008 &Paul et al 2009). Five 
studies included individuals with leg ulcers (Dumville et al 2009, Opletalova et al 2012, Mudge 
et al 2014, Wollina et al 2002 and Courtenay et al 2000).  Two studies included those with 
pressure ulcers (Sherman et al 1995 & Sherman, 2002). One study included individuals with 
either diabetic foot ulcers or pressure ulcers (Wang et al 2010).  The systematic review analyses 
a study related to leg ulcers (Gray, 2008).  
 
4.5.3 Geographical Location 
In terms of geographical location two studies were conducted in the UK (Courtenay et al 2000 
and Mudge et al 2014) one in the UK and Hungary (Dumville et al 2009), one in China (Wang 
et al 2010) three in USA (Sherman, 2002, Sherman et al 1995 and Sherman, 2003) one in 
Germany (Wollina et al 2002) one in France (Opletalova et al 2012) one in Egypt (Tantawi et 
al 2007), one in Malaysia (Paul et al 2009) one in Poland (Jarczyk et al 2008) and one in 
Jerusalem (Mumcuoglu et al 1998). The remaining paper was a systematic review. 
 
4.5.4 Study Settings 
One study was set in community health ulcer clinics, hospital outpatients clinics, urban and 
rural setting (Dumville et al 2009). Another study was set in a hospital setting and outpatient 
clinic (Mumcuoglu et al 1998).  Two studies did not specify their study setting (Sherman 2003 
and Wollina et al 2002) whereas a further eight studies took place in hospital settings (Paul et 
al 2009, Jarczyk et al 2008, Tantawi et al 2007, Opletalova et al 2012, Courtenay et al 2000, 
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Sherman et al 1995, Sherman 2002 and Wang et al 2010).  One study took place in hospital, 
community, nursing home, research clinic setting and patients’ own homes (Mudge 2014). The 
remaining paper was a systematic review. 
 
4.5.6 Intervention 
Larvae were the intervention used in these studies, either bagged larvae or loose larvae or both. 
Some studies compare larvae to conventional methods of treatment for example surgical 
debridement or autolytic debridement (Sherman, 2002, Sherman, 2003, Paul et al 2009, 
Dumville et al 2009, Wang et al 2010, Opletalova et al 2012 and Mudge et al 2014).  Other 
studies monitor the wound bed progress pre and post larvae therapy (Sherman et al 1995, 
Mumcuoglu et al 1998, Courtenay et al 2000, Wollina et al 2002, Tantawi et al 2007, Jarczyk 
et al 2008)  The final study was a systematic review (Gray,2008) which reviewed a study by 
Wayman et al (2000) that study compared larvae to hydrogel. 
 
4.5.6.1 Larvae Therapy with no Comparator 
In the first study, Sherman et al (1995) used the larvae species Phaenicia sericata (also known 
as Lucilia sericata) to treat pressure ulcers in spinal cord injury patients. The pressure ulcers 
varied from a grade 2 to a grade 4.  Sherman et al (1995) prepared and sterilised their own 
larvae by sterilising their eggs and hatching the larvae. Of the twenty patients who had larvae 
therapy, eight of those patients were followed for three to four weeks before the larvae were 
applied while they were still receiving conventional treatment.  Conventional treatment 
included the wound being cleansed three times daily with normal saline or use of an iodine 
dressing combined with surgical debridement. The loose larvae were placed on the wounds and 
covered with a sterile porous dressing. They were left in place for a period of 48-72 hours. One 
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to two cycles of larvae therapy were applied each week for an average of one to two weeks. In 
between larvae cycles the wounds received wet to dry dressings of sodium hypochlorite if their 
wounds were necrotic or normal saline if their wounds were clean, this was undertaken eight 
hourly.  Sherman et al (1995) does not state specifically who changes the dressings or who 
performed the wound assessment. The wounds were monitored once a week both visually and 
photographically.   
 
4.5.6.2 Larvae Therapy with no Comparator 
In the second study by Mumcuoglu et al (1998) larvae therapy was used for the treatment of 
27 diabetic foot ulcers in 22 patients. Mumcuoglu et al (1998) also used the larvae species 
Phaenicia (Lucilia) sericata, which they obtained from a lab. Loose larvae were placed on the 
wounds and covered with surgical pads to absorb any excess exudate from the wound.  The 
larvae were left on the wound for 24 to 72 hours and changed two to five times a week.  When 
changing the larvae they were washed out of the wound with sterile saline. Each wound was 
photographed at least once a week and the quality of the wound recorded. The larvae treatment 
lasted for a mean of 12 days. Mumcuoglu et al (1998) did not specifically state who dressed 
the wounds. 
 
4.5.6.3. Larvae Therapy with no Comparator 
In the third study by Courtenay et al (2000), seventy patients with leg ulcers of mixed aetiology 
were treated with larvae. The exact species was not identified, or if the larvae were loose or 
bagged. The nurses treating the patients changed the larvae and the larvae were left on the 
wound for a mean of three days.  Each wound received larvae therapy an average of three times 
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in total. The type of dressing used with the larvae was not disclosed nor how the progress of 
the wound was recorded. 
 
4.5.6.4 Larvae Therapy with no Comparator 
In the fourth study by Wollina et al (2002) 30 patients with leg ulcers of mixed aetiology had 
the Lucilia sericata larvae applied to their wounds. The loose larvae were applied to the wound 
with vacuseal gel and covered by a sterile mesh, a further absorbent dressing was placed on top 
to absorb any exudate. No information is provided pertaining to the vacuseal gel. The larvae 
were left in place for 1-4 days and were removed when the patient was in the shower. The 
quality of the wound was assessed using a wound score. Only two patients received further 
applications of larvae therapy. Wollina et al (2002) does not specifically state who changed the 
dressings.  
 
4.5.6.5 Larvae Therapy vs. Conventional Treatment 
In the fifth study by Sherman (2002) one hundred and three patients had one hundred and forty-
five pressure ulcers. Phaenicia (Lucilia) sericata larvae were used to treat pressure ulcers in the 
study group which consisted of sixty-one pressure ulcers in fifty patients. The control group, 
which consisted of eighty-four ulcers in seventy patients, was treated conventionally, this 
varied from surgical debridement, to hydrogels, to chemical debriding agents, to topical anti-
microbial agents and to saline moistened gauze. The control groups’ ulcers were dressed as per 
the primary care team instructions. Whereas he study group had loose larvae applied to their 
pressure ulcer, with a hydrocolloid dressing surrounding the edge of the wound. The wound 
was covered by a porous sheet and glued to the hydrocolloid dressing to keep the larvae in the 
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wound. A layer of gauze was placed on top of the porous sheet to soak up the exudate; this 
gauze was changed every 4 to 8 hours because of the high level of exudate. The larvae remained 
in place for 48 hours and two cycles of larvae were applied each week for five to six weeks. 
Normal saline or sodium hypochlorite soaked gauze was placed on the wound in between 
larvae cycles. Sherman (2002) does not mention who changed the dressings of either group. 
 
4.5.6.6 Larvae Therapy vs. Conventional Treatment 
In the sixth study, Sherman (2003) compared conventional therapy to larvae therapy as a form 
of debridement.  For the first two weeks observation, patients received conventional treatment 
as prescribed by their primary care team.  If their ulcer did not improve larvae therapy was 
commenced.  Eighteen patients with twenty diabetic foot ulcers were included in this study. 
One group (n=6) were treated with loose Phaenicia (Lucilia) sericata larvae, another group 
(n=6) were treated with conventional methods which were saline soaked gauze changed every 
8 hours, topical antimicrobials three times daily, hydrogel applied 1-3 times daily, hydrocolloid 
pads changed 1-2 weekly or surgical debridement for an average of 5.3 weeks. The third group 
(n=8) were treated with a conventional method first then larvae therapy. Sherman (2003) 
disinfected their own larvae and applied them to the wounds and covered them with loose 
gauze, a hydrocolloid dressing was placed around the edge of the wound and a porous dressing 
was glued to the hydrocolloid dressing to keep the larvae on the wound bed. Light gauze was 
then placed on top to absorb the excess exudate, which was changed every 4-6 hours. The 
larvae were left in place for 48 hours. One to two cycles of larvae therapy were applied each 
week for an average of 4.7 weeks. Normal saline or sodium hypochlorite moistened gauze was 
placed on the wounds in between cycles of larvae and when the larvae treatment was finished. 
The larvae were removed from the wound by wiping them off with wet gauze. The wounds 
53 
 
were assessed using digitized photographic images. Sherman (2003) does not state who dressed 
the wounds.  Wounds were assessed weekly and photographed for eight weeks or until hospital 
discharge. 
 
4.5.6.7 Larvae Therapy with no Comparator 
In the seventh study Tantawi et al (2007) use loose Lucilia sericata larvae to treat ten patients 
with thirteen diabetic foot ulcers. The edge of the wounds were covered in an adhesive silk 
plaster, the loose larvae are applied to the wound by the lead author. A fine nylon mesh was 
placed over the larvae to keep them in place and was secured with tape. Gauze was placed over 
the larvae to soak up the excess fluid; this was replaced every 12 hours. The larvae were 
changed every 3 days. This took place once a week for a mean of 1.9 weeks. The larvae were 
removed using wet gauze.  Saline soaked gauze was placed on the wounds in between the 
larvae cycles. Photographs were taken each week; ulcer circumference was measured by 
tracing the wound. The surface area of the wound and percentage of necrotic tissue on the 
wound were measured using a mechanical planimeter every week. A vascular surgeon visually 
examined each wound every week to monitor the degree of necrotic or granulating tissue 
present. 
 
4.5.6.8 Larvae Therapy with no Comparator 
In the eight study by Jarczyk et al (2008) Lucilia sericata larvae were used as debridement for 
diabetic foot ulcers in four patients. Loose larvae were used on the wounds; the edges of the 
wound were protected with a hydrocolloid dressing. The larvae were covered with a sterile 
piece of gauze, which was glued to the hydrocolloid dressing and an outer layer of absorbent 
gauze was then applied. Jarczyk et al (2008) also applied a moist bandage around the dressing 
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to provide the larvae with a source of moisture. The gauze and moist bandage were changed 2-
3 times daily and the larvae changed every 2-3 days for a mean of 12 days. Photographs were 
taken of the wounds before and after larvae therapy. Jarczyk et al (2008) do not state who 
undertook changing the dressings. 
 
4.5.6.9 Larvae Therapy with no comparator 
The ninth study by Gray (2008) is a systematic review. Two of the studies (Sherman, 2002 and 
Sherman, 2003) reviewed by Gray (2008) have already been discussed by the writer. However, 
a further study by Wayman et al (2000), included by Gray (2008) was reviewed for the purpose 
of the writer’s review.  This study included twelve patients with leg ulcers. Larvae therapy was 
compared to a hydrogel dressing however the number of patients in each group was not 
disclosed. In the larvae group, the wound edge was surrounded by a hydrocolloid dressing; 
loose larvae were applied loose and covered with a sterile mesh. The larvae were left on the 
wound for 72 hours. The duration of the larvae treatment is not mentioned. 
 
4.5.6.10 Larvae Therapy vs. Conventional Treatment 
In the tenth study, Paul et al (2009) compared the larvae of the Lucilia cuprina with 
conventional debridement methods in 59 patients with diabetic foot ulcers. In the study group 
(n=29) larvae were applied to the wound loose, covered with light gauze and then covered with 
a transparent sticky dressing with holes to allow the exudate to drain. An absorbent dressing 
was then placed on top and covered with a light crepe bandage; these outer dressings were 
changed as required. The wound was washed out with normal saline after 48 hours, removing 
any larvae. This was continued until complete debridement had occurred. If no improvement 
was observed after three cycles of larvae therapy, the treatment was discontinued. The control 
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group (n=30) had their wounds dressed every day with normal saline, surgical debridement 
was carried out as required. Paul et al (2009) devised their own grading system for evaluating 
the progress of the wounds. The study group and the control group had three grades: healed, 
unhealed and others. The outcomes for the study group were divided into four subgrades and 
the control group divided into three subgrades. Paul et al (2009) state that various health care 
professional carried out the wound dressings changes. 
 
4.5.6.11 Larvae Therapy vs. Hydrogel 
The eleventh study by Dumville et al (2009) was a three armed RCT of 267 patients with leg 
ulcers.  The study was divided into two phases; the first phase was the debridement phase and 
the second phase involved the ongoing treatment of the wound. The patients received either 
bagged or loose Lucilia sericata larvae or hydrogel as a form of debridement. The first group 
(n=94) received loose larvae. Zinc paste bandage or a hydrocolloid dressing was placed around 
the edge of the wound; the larvae were kept in place by using a mesh which was stuck to the 
dressing on the border of the wound. If the wound was dry, a layer of saline moist gauze was 
placed on top of the mesh and this was replaced as necessary. The larvae remained on the 
wound for 3-4 days and were removed by flushing the wound with normal saline. The nurse 
dressing the ulcer assessed the ulcer and decided if it needed a further application or not. If 
more larvae were required, purilon hydrogel (which is not toxic to larvae as it does not contain 
propylene glycol) was applied to the wound while waiting for the larvae to arrive. This 
treatment lasted an average of 11.95 days.  The second group (n=86) had bagged larvae on their 
wounds, which were applied directly onto the wounds, which had the hydrocolloid dressing or 
zinc paste on the surrounding wound edges. A simple light bandage covered the wound to keep 
the larvae in place and they remained on the wound for 3-4 days. As with the loose larvae group 
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if further debridement was required purilon hydrogel was applied until the larvae were 
available. This treatment lasted an average of 12.84 days. The patients in the control group 
(n=87) were treated with the conventional method of hydrogel. Hydrogel was placed directly 
onto the wound and covered with a knitted viscose dressing. The nurses discontinued using 
hydrogel once they considered the wound to be debrided. This treatment lasted an average of 
43.17 days. The patients in the control group who had an ABPI of 0.6 or greater were also 
offered three layered compression bandaging, if their ABPI was greater than 0.8 they were 
offered four layered bandaging. It was not possible for the patients in the larvae groups to 
receive compression bandaging, as the larvae wound not survive. The debridement phase was 
to last a minimum of six weeks or until complete debridement was achieved. Nurses took 
photographs of each ulcer every week for six months then monthly until the ulcer was healed. 
The second phase continued with treatment of the wound until healing. 
 
4.5.6.12 Larvae Therapy vs. Conventional Treatment 
In the twelfth study by Wang et al (2010) twenty-five patients with diabetic foot ulcers and 
eighteen patients with pressure ulcers after spinal cord injuries were treated with larvae therapy 
or a conventional method. Twenty-three patients were treated with larvae therapy and twenty 
patients were treated with conventional therapy. Wang et al (2010) collected eggs from the 
eyes of scomberomorus niphonius (a Japanese mackerel) sterilised them and placed them in 
sterile vials to clone. Once cloned the larvae of Lucilia sericata were disinfected. Dry wounds 
were cleansed with hypertonic saline to give the larvae moisture. The wound edges were 
covered by sterile saline gauze; the loose third stage larvae were placed on the wound and 
covered with a sterile nylon mesh which was taped to the surrounding skin. A final layer of 
gauze was placed around the cage like dressing to absorb any wound exudate, this was placed 
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lightly so as not to suffocate the larvae. The number of larvae on the wound was recorded. The 
entire dressing and larvae were changed every day. The wounds were also assessed every day; 
however how the ulcers were assessed is not mentioned. The mean time to complete 
debridement was 3.1 days. The changing of the dressings continued until the wounds were 
healed. The control group had a dressing applied daily with normal saline, surgical debridement 
was preformed if necessary until the lesion had healed. The mean time to complete debridement 
was 6.3 days.  Patients were not given antibiotics during their course of treatment. The patients 
with pressure ulcers had a soft pad inserted behind their back so as not to squash the larvae. 
Information pertaining to who changed the dressings was not disclosed. 
 
4.5.6.13 Larvae Therapy vs. Conventional Treatment 
The thirteenth study is an RCT by Opletalova et al (2012) of one hundred and nineteen patients 
with leg ulcers. The study group (n=51) had larvae of Lucilia sericata applied to their wounds, 
which were supplied from a lab. The larvae were placed in a polyester bag that was placed 
directly on the wound bed, the larvae were able to debride through the bag which had been 
sealed. The dressings were changed twice a week for two weeks, however, by whom is not 
stated. The control group (n=54) had hydrogel on the dry wounds covered with a hydrocolloid 
dressing and the sloughy wounds had an alginate based dressing. The control group had their 
wounds surgically debrided three times a week. All of the patients in the study were discharged 
from hospital on day 15 with hydrocellular, hydrocolloid or alginate dressing’s insitu and were 
followed up on day 30. The wounds were photographed on days 1, 8, 15 and 30 to monitor 
their progression. The photographs were evaluated by an experienced nurse who had no 
involvement with dressing any of the wounds. 
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4.5.6.14 Larvae Therapy vs. Conventional Treatment 
The final study by Mudge et al (2014) compared larvae therapy to hydrogel in eighty-eight 
patients with leg ulcers. The specific species of larvae used in this study is not mentioned. The 
ulcers were cleansed with saline. Sudocrem was applied to the edges of the wound and larvae 
or hydrogel was applied. Whether the larvae were bagged or loose is not stated. A secondary 
dry dressing was applied to the wound and kept in place with a light bandage. Compression 
therapy was then applied. The wounds were reviewed every three to four days until 
debridement occurred or for a maximum of three weeks. Photographs were taken on each 
dressing change and assessed by a blind evaluator. 
 
4.6 Quality Appraisal of Included Studies 
All studies excluding the systematic reviews were quality appraised using the EBL critical 
appraisal check list (Glynn, 2006). In this checklist, if the scores for the total validity of the 
study was greater than or equal to 75% (yes/total) or [(no + unclear)/total] was less than or 
equal to 25% then the study was considered valid. 
The mean of the thirteen studies critically appraised by the EBLIP critical checklist was 72%. 
Dumville et al (2009) and Opletalova et al (2012) studies scored the highest at 92% (see 
appendix 20 and 22 respectively). The lowest was Mumcuoglu et al (1998) at 48% (see 
appendix 12).  An overall percentage of the thirteen included studies is displayed in table one 
below. 
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Table 1: EBL Critical Appraisal Checklist Percentage 
Study Title EBL Checklist Percentage 
Sherman (1995) 74% 
Mumcuoglu et al (1998) 48% 
Courtenay et al (2000) 65% 
Wollina et al (2002) 52% 
Sherman (2002) 69% 
Sherman (2003) 68% 
Tantawi et al (2007) 74% 
Jarczyk et al (2008) 65% 
Paul et al (2009) 78% 
Dumville et al (2009) 92% 
Wang et al (2010) 76% 
Opletalova et al (2012) 92% 
Mudge et al (2014) 80% 
 
 
4.7 Quality Appraisal of Systematic Reviews and Meta-analysis 
The systematic review included in this review was quality appraised using the PRISMA 
checklist (Moher, 2009).  Gray (2008) report fourteen out of the twenty-seven questions in the 
checklist. (See appendix 35) 
 
4.8 Primary Outcome Results 
 
4.8.1 Rate of Debridement 
4.8.1.1 Larvae Therapy with no Comparator 
In the study by Sherman (1995) eight of the twenty patients who received larvae therapy for 
their pressure ulcers were followed three- four weeks prior to the introduction of larvae therapy. 
Therefore only these eight patients were included in the final results. On commencement of the 
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study 5 patients had 0-25% necrotic tissue on their wound and 3 patients had 51-100% necrotic 
tissue. The patients that had 20% or more necrotic tissue on their wound, after conventional 
therapy was discontinued, their wounds were less than half debrided. Once larvae therapy was 
commenced all of these ulcers were completely debrided within one to two weeks (mean of 1.4 
weeks). All of these ulcers had previously existed for four weeks. 
 
4.8.1.2 Larvae Therapy with no Comparator 
In the study by Mumcuoglu et al (1998) twenty-two diabetic patients with twenty-seven foot 
ulcers had larvae therapy commenced.  All wounds existed for a mean of 10.3 months (range 
1-48 months).  The period of larvae treatment ranged from 1 to 45 days (mean 5.7). Twelve of 
the twenty-two patients’ wounds were fully debrided within one to eight days of larvae therapy 
commencing. In total there was complete debridement in 66.7% of the wounds (18 wounds), 
significant debridement in 22.6% (6 wounds) and partial debridement in 7.4% (2 wounds).  
There was no difference in 3.7% of wounds (1 wound). Three of the wounds had poor outcome 
as the wounds were on the foot, the patients were ambulatory and squashed the larvae. 
 
4.8.1.3 Larvae Therapy with no Comparator 
Courtenay et al’s (2000) had seventy patients with leg ulcers. The average area of the leg ulcers 
were 80cm2, including 8cm2 of granulation tissue and 52cm2 of slough and necrotic tissue. The 
larvae therapy lasted for a mean of three days. After larvae therapy fifty-nine of the seventy 
leg ulcers were reported on. Thirty of the leg ulcers were fully debrided, twenty ulcers were 
partially debrided, there was no change to eight of the wounds and one ulcer deteriorated. 
Tissue granulation had increased by 21cm2 (26%). The average size of the wound decreased 
by 5% during the study and the overall area of slough and necrotic tissue decreased by 68%.  
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4.8.1.4 Larvae Therapy with no Comparator 
In the study by Wollina et al (2002), thirty patients had larvae placed on their leg ulcers. The 
treatment lasted a mean of 3.3 days. Two patients received larvae therapy more than once. 
Wollina et al (2002) documented the wound score of the wound before and after the first 
application of larvae therapy. The score assesses the quality of the wound and it incorporated 
slough, exudation, inflammation of surrounding skin, and granulation. The higher the score the 
lower the quality of the wound and the maximum score possible being 15. The mean score 
before larvae therapy was started was 13.5, after larvae therapy the mean score was 6.3.  
 
4.8.1.5 Larvae Therapy vs. Conventional Treatment 
In Sherman’s (2002) study one hundred and three patients had one hundred and forty-five 
pressure ulcers and sixty-seven patients with ninety-two pressure ulcers were included in the 
final results. Furthermore, forty-nine of these wounds were treated with conventional therapy, 
while forty-three wounds had larvae therapy. The wounds that received larvae were 60% larger 
in size than the conventionally treated wounds before treatment. Before commencement of 
either treatment the conventional groups’ wounds were 34% covered in necrotic tissue and the 
larvae group had 31% necrotic tissue. At the end of the study, 80% of the larvae treated wounds 
were completely debrided, while only 48% of the conventionally treated wounds were fully 
debrided (p= 0.021).  Within three weeks of commencing treatment the larvae treated wounds 
had twice as much granulation tissue than the conventionally treated wounds (p <0.001).  The 
wounds in the larvae group were fully debrided in a mean of 8 weeks (range 6-10 weeks), in 
the conventional group it took a mean of 17 weeks to fully debride the wounds (range 7-28). 
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4.8.1.6 Larvae Therapy vs. Conventional Treatment 
In the three armed study by Sherman (2003) eighteen patients had twenty diabetic foot ulcers.  
Six patients had larvae therapy, six had conventional therapy and a further eight had 
conventional therapy first then larvae therapy. The results were presented in two groups, larvae 
group and conventional group. In total fourteen patients had larvae therapy and fourteen had 
conventional therapy. The mean duration of the treatment was 5.3 weeks (range 6.4weeks) for 
the conventional group and a mean of 4.7weeks (range 6 weeks) for the larvae group. The size 
of the wounds in the larvae group was on average larger than the conventional group. The 
average size of a wound in the larvae group was 13.3cm2 (range 9-42cm2) while the average 
conventional therapy group wound size was 6.3cm2 (range 5-15.5cm2). There was little 
difference in the percentage of necrotic tissue of the total surface area of the wound between 
the two groups. Initially, the conventional group had a mean of 44% necrotic tissue (range 22-
67), the larvae therapy group had a mean of 38% (range 22-55). After two weeks of treatment 
the conventional group had a mean of 39% necrotic tissue and the larvae therapy had a mean 
of 7% necrotic tissue. Baseline granulation tissue for the larvae group was 19% and 18% for 
the conventional group.  After four weeks granulation tissue for larvae group was 56% and 
15% for the conventional group. The larvae treated ulcers were completely debrided within 
four weeks of initiating treatment and had 56% of healthy granulation tissue, whereas the 
conventionally treated ulcers at 5 weeks still had 33% necrotic tissue on their wounds and 15% 
of granulation tissue (p = 0.001). 
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4.8.1.7 Larvae Therapy with no Comparator 
Tantawi et al (2007) had ten patients with thirteen diabetic foot ulcers. All ten patients were 
treated with larvae therapy. The average surface of the wounds was 23.5cm2 (range 1.3 -
63.1cm2). The average of necrotic tissue per wound was 74.9% (range 29.9-100). All ulcers 
were completely debrided within a mean of 1.9 weeks (range 1-4 weeks). The mean decrease 
in percentage of necrotic tissue in the surface of the wound was 64.7% per week (range 24.9-
100). 
 
4.8.1.8 Larvae Therapy with no Comparator 
Jarczyk et al (2008) had four patients in this study with diabetic foot ulcers. The mean surface 
area of the four wounds was 47cm2 (range 14-139cm2). The duration of the therapy was a mean 
of 12 days (range 9-18 days). Jarczyk et al (2008) devised a debridement index formula to 
calculate the rate of debridement before and after treatment. The formula is:  
Debridement index = 100 – X1/X2 x100 
Furthermore, X1 equals percentage of necrosis and purulent exudate before treatment and X2 
is percentage of necrosis and purulent exudate after treatment. The rate of debridement after 
three days treatment using the debridement index in three ulcers ranged from 76.5% to 56.8%. 
Larvae therapy was ineffective for the fourth ulcer. Complete debridement was achieved in 
three ulcers in 18 days. 
 
4.8.1.9 Larvae Therapy vs. Conventional Treatment 
In Paul et al’s (2009) study fifty-nine patients with diabetic foot ulcers were treated. Moreover, 
twenty-five of these patients had larvae therapy whilst twenty-nine patients had conventional 
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therapy and five patients did not complete the study. Paul et al (2009) devised their own 
outcome scoring system. The study group and the control group outcomes had three possible 
grades: healed, unhealed and others. Furthermore, the outcomes for the study group were 
divided into four subgrades and the control group divided into three subgrades. This study does 
not give any other information on wound size, percentage of necrotic tissue. The results are 
reported as per Paul et al’s (2009) own scoring system, which is difficult to interpret. However, 
the authors report no statistically significant difference between larvae therapy and 
conventional methods as a form of debridement. 
 
4.8.1.10 Larvae Therapy vs. Hydrogel 
In the three armed RCT by Dumville et al (2009) ninety-four patients were subjected to loose 
larvae, eighty-six patients to bagged larvae and eighty-seven received hydrogel for their leg 
ulcers. The average ulcer size in the loose larvae group was 23.2cm2, in the bagged larvae 
group was 29.4cm2 and 19.8cm2 in the hydrogel group. The average time for debridement in 
the loose larvae group was 11.95 days, the bagged larvae group was 12.84 days and the 
hydrogel group 43.17 days.  At day 20 of the trial 58% of patients receiving larvae therapy 
(both bagged and loose) were debrided compared to 10% of the patients that were receiving 
hydrogel. The median time to debridement in the loose larvae group was 14 days, in the bagged 
larvae group 28 days, and the median time to debridement in the hydrogel group was 72 days. 
There was no statistically significant difference between either larvae group (risk ratio: 0.87; 
95% CI 0.50-1.51; p=0.62) as shown in figure 2 
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Figure 2: Forest Plot 1- Loose larvae vs. Bagged larvae -No. not debrided 
 
 
However, with data from the two larvae groups combined and compared to the hydrogel group 
there was a statically significant difference in rate of debridement (risk ratio: 0.59, 95% CI 0.4-
0.87; p = 0.008) as shown below in figure 3. 
 
Figure 3: Forest Plot 2- Larvae vs. Hydrogel- No. not debrided 
 
 
4.8.1.11 Larvae Therapy vs. Hydrogel 
In the Mudge (2014) study the larvae group had six patients with 25-50% necrosis at baseline 
and forty patients with >50% necrosis. In the hydrogel group ten patients had 25-50% necrosis 
and thirty-two patients had >50% necrosis. After the intervention in the larvae group twenty-
four patients had 20-25% necrosis and nineteen had >50%. In the hydrogel group twenty-six 
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patients had 25-50% necrosis and sixteen patients had >50% necrosis. A total of 31 ulcers 
(67.4%) were fully debrided in the larvae group (n=46) within 3 weeks, whereas only 11 ulcers 
(26.2%) in the hydrogel group (n=42) were fully debrided. When the patients who dropped out 
of the study were excluded the rate of debridement for each group increased.  In the larvae 
group 96.9% (n=32) had there ulcers fully debrided and in the hydrogel group 34.4% (n=32) 
had there ulcers fully debrided within 3 weeks.  The results show a statistically significant 
difference in favour of the larvae group (risk ratio: 0.44, 95% CI 0.28-0.69; p = 0.0004) as 
shown in figure 4. 
 
Figure 4: Forest Plot 3 – Larvae vs. Hydrogel – No not debrided 
 
 
When both studies are combined (Dumville et al 2009 and Mudge et al 2014) the revman 
analysis shows a statistically significant difference between the larvae and the hydrogel treated 
groups, in favour of the larvae group (total risk ratio: 0.53, 95% CI0.39-0.71; p = 0.0001) as 
shown in figure 5. 
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Figure 5: Forest Plot 4 Larvae vs. Hydrogel – No. not debrided 
 
 
 
4.8.1.12 Larvae Therapy vs. Conventional Treatment 
In Wang et al (2010) study, there were two types of wounds, diabetic foot ulcers and pressure 
ulcers. In the diabetic foot ulcer group 12 patients had conventional therapy and 13 patients 
had larvae therapy. Wang et al (2010) reported the results as mean time to granulation in days 
and the results are displayed in figure 6. There was a statistically significant difference in mean 
time to granulation (Mean Difference -3.20, 95% CI-4.14 to-2.26; p=0.00001). The larvae 
group required less time to achieve this outcome. 
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Figure 6: Forest Plot 5– DFU Larvae vs. Control group 
 
  
In the larvae pressure ulcer group eight patients had conventional therapy and 10 patients had 
larvae therapy. The results are displayed in figure 7 as the number of days to granulation. As 
can be seen, there is a statistically significant difference between the groups, with the larvae 
group taking less days to achieve granulation (Mean Difference -2.30, 95% CI -3.23 to -1.37; 
p=0.00001). 
 
Figure 7: Forest Plot 6 – PU Larvae vs. Control group 
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4.8.1.13 Larvae Therapy vs. Conventional Treatment 
In the study by Opletalova et al (2012) 105 patients were included in the study, 51 received 
larvae therapy and 54 patients received conventional therapy. Data was collected on day 1, 8, 
15 and 30. The primary outcome for Opletalova et al (2012) was mean reduction in necrotic 
tissue at day 15.  No statistically significant difference between the groups was found following 
revman analysis (Mean Difference 1.60, 95% CI -10.57 to 13.77; p=0.80), see figure 8. 
 
Figure 8: Forest Plot 7- Larvae vs. Conventional therapy 
 
 
4.9 Primary Results from Systematic Reviews 
Gray (2008) reviewed another study by Wayman et al (2000) and the results of this study 
showed that larvae was statistically significantly quicker form of debridement than hydrogel (p 
= 0.0039). Gray (2008) also reviewed studies that were reported by this writer Sherman (2002) 
and Sherman (2003).   
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4.10 Results of Secondary Outcomes 
 
4.10.1 Rate of Healing 
 
Sherman (1995) reports there was an average increase of pressure ulcers size of 21.8% per 
week before larvae therapy, however, once larvae therapy was initiated there was a reduction 
in ulcer size of 22% on average per week. There was no report on complete healing. 
 
Conversely, Courtenay et al (2000) reported that the average wound size reduced by 5% after 
larvae therapy. However, no report was given on complete healing. 
 
Sherman (2002) used a formula to determine healing rate obtained from a different study.  The 
formula is: 
(surface area at time t2) – (surface area at time t1)                              ÷ t2 - 1 
[(circumference at time t1) + (circumference at time t2)]/2 
 
Furthermore, t1 equals initial time of observation, t2 equals final time of observation, t2 – 1 equals 
the period of observation in weeks.  The healing rate for the larvae group and the conventional 
group at week eight was 0.0096 and 0.027 respectively. However, 79% of the larvae treated 
pressure ulcers decreased in surface area within four weeks, whereas in the conventional group 
44% of the wounds had decreased.  Furthermore, 39% of the larvae therapy group wounds 
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healed completely whereas, 21% of the conventional treated wounds healed. On average it took 
the larvae group wounds 12 weeks to heal and the conventional group 13.4 weeks. 
 
In a further study by Sherman (2003) the above formula used by Sherman (2002) is also applied 
to rate of healing.  The healing rate at week eight for the larvae group was 0.07 and -0.02 for 
the conventional group.  Furthermore, 36% of the larvae treated diabetic foot ulcers completely 
healed and 21% of the conventional group. It took on average 15 weeks for the larvae groups 
ulcers to completely heal and 18 weeks for the conventional group. 
 
Tantawi et al (2007) states that the surface area of the diabetic foot ulcers decreased by 16.1% 
and 2.5cm2 per week. Furthermore, 84.6% of the ulcers completely healed in an average of 7.3 
weeks. 
 
Whereas, Mumcuoglu et al (1998), Wollina (2002), Jarczyk et al (2008), Paul et al (2009) and 
Mudge et al (2014) did not report any wound healing rates or reduction in wound size. 
 
Dumville et al (2009) reported that 48.9% of ulcers in the loose larvae group completely healed 
(46/94), 47.7% in the bagged larvae group completely healed (41/86), and 42.5% of the 
hydrogel arm ulcer completely healed (37/87). Revman analysis found no statistically 
significant difference between the larvae groups or the hydrogel groups (Odds Ratio1.26, 95% 
CI 0.75 – 2.12; p = 0.37) (see figure 9). Furthermore, with both larvae groups’ results combined 
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together, there is still no statistically significant difference in healing rates (Odds Ratio 1.05, 
95% CI 0.59 – 1.89; p = 0.87) (see figure 10). 
 
 
Figure 9: Forest Plot 8 Loose larvae vs. Hydrogel - Healing rate 
 
 
Figure 10: Forest plot 9 Loose larvae vs. Bagged larvae - Healing rate 
 
 
Wang et al (2010) reported healing as mean time to healing in days for both the diabetic foot 
ulcer group and the pressure ulcer group. For the diabetic group, there is a statistically 
significant difference between the control and the larvae group, with the larvae group achieving 
healing more quickly (Mean Difference -13.20, 95% CI -23.42 to -2.98; p=0.001) (see figure 
11) For the pressure ulcer group, a similarly statistically significant difference between the 
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control group and larvae group is seen, with the larvae group  achieving healing more quickly 
(Mean Difference -11.90, 95% CI -22.53 to -1.27; p=0.03) (see figure 12). 
 
Figure 11: Forest Plot 10 DFU Larvae vs. Control Group -Time to healing 
 
 
Figure 12: Forest Plot 11 PU Larvae vs. Control -Time to healing 
 
 
 
Opletalova et al (2012) reports no statistically significant difference in wound healing rates on 
day 8 or 30 but at day 15 there was a statistically significant difference in mean wound ulcer 
reduction size in favour of the larvae therapy group. (Mean Difference -22.80, 95% CI -42.03 
to -3.57; p=0.02) (see figure 13). 
 
 
74 
 
Figure 13: Forest Plot 12 Larvae vs. Control-Wound surface reduction day 15 
 
 
4.10.2 Pain 
Sherman et al (1995) and Jarczyk et al (2008) did not report any findings of pain. Whereas, 
Mumcuoglu et al (1998) reported that 6/22 diabetic foot ulcers patients complained of pain 
during larvae therapy treatment. Similarly, Courtenay et al (2000) reported that 23/70 leg ulcer 
patients reported pain while on larvae therapy treatment. Indeed, 6 patients said the pain was 
severe, 11 moderate and mild in 6 patients. Furthermore, Wollina et al (2002) stated that mild 
pain was a common side effect of larvae therapy and two patients required oral analgesics. 
Conversely, Sherman (2003) stated that 2 patients who received larvae therapy complained of 
pain but these two patients also complained of pain when treated conventionally. Similarly, 
Sherman (2002) stated that 2/50 larvae treated patients complained of pain, but these patients 
had also complained of pain while being treated conservatively. However, there were no reports 
of pain from patients in the conservatively treated group. Whereas, Tantawi et al (2007) stated 
that no patients receiving larvae therapy complained of pain during this study. Furthermore, 
Opletalova et al (2012) observed that pain was mild in both the larvae and the conventionally 
treated groups. 
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Paul et al (2009) reported that two patients in the larvae therapy group out of twenty-nine were 
unable to finish the study due to the pain. There were no complaints of pain reported in the 
conventional treated group. Similarly, Dumville et al (2009) recorded patients’ pain at baseline 
and over a three monthly period.  Dumville et al (2009) observed that there was a significant 
difference in pain levels between the larvae groups and the hydrogel groups, with the larvae 
groups experiencing more pain (p=0.001). In addition, Wang et al (2010) stated that one patient 
out of twenty-three in the larvae group complained of severe pain. There were no other reports 
of pain. 
 
Mudge et al (2014) reported that one patient in the hydrogel arm and eight patients in the larvae 
arm withdrew from the study due to pain. However, at the final visit Mudge et al (2014) stated 
there was no statistically significant difference in pain levels in either group (Mean Difference 
-2.54, 95% CI -13.33 to 8.25; p=0.64) (see figure 14). 
 
Figure 14: Forest Plot 13 Larvae vs. Hydrogel - Pain on final assessment 
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4.10.3 Health Related Quality of Life 
Sherman et al (1995), Mumcuoglu et al (1998), Courtenay et al (2000), Wollina et al (2002), 
Sherman (2002), Sherman (2003), Tantawi et al (2007), Jarczyk et al (2008), Paul et (2009), 
Wang et al (2010), Opletalova et al (2012) and Mudge et al (2014) do not report any outcome 
on health related quality of life. 
 
Dumville et al (2009) recorded health related quality of life at baseline, 3, 6, 9 and 12 months 
by means of a questionnaire. Dumville et al (2009) observed that health related quality of life 
was low in all three arms of the study in terms of physical and mental health compared to a 
similar age group in USA. Social functioning was also measured at baseline, 3, 6, 9 and 12 
months and was similar between the groups. 
 
4.10.4 Acceptability of Larvae Therapy 
Sherman et al (1995), Mumcuoglu et al (1998), Courtenay et al (2000), Wollina et al (2002), 
Sherman (2003) Jarczyk et al (2008) Wang et al (2010), Opletalova et al (2012) or Mudge  et 
al (2014) do not report any outcomes of patient or staff acceptability of larvae therapy. 
 
Sherman (2002) reports that when asked 95% of patients were willing to try larvae therapy as 
a wound intervention. However, it was not very well accepted by nursing staff, they tended to 
avoid dressing wounds with larvae therapy or tried to give the job to a temporary or new 
member of staff. 
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In a further study, Tantawi et al (2007) stated that patients were willing to try larvae therapy 
once they were shown photographs of other peoples’ wounds that had successful outcomes.  
Staff acceptability was not reported on. Similarly, Paul et al (2009) stated that most patients 
were accepting of larvae therapy. There was no reporting on staff acceptability. 
 
Dumville et al (2009) recruited 18 people to a qualitative study to assess acceptability of larvae 
therapy. 83% (15/18) were willing to accept larvae therapy, 11% (2/18) were not and 6% (1/18) 
were unsure. One person was willing to change her mind and accept larvae therapy once they 
were aware larvae were available in bagged form. 22 nurses were also enrolled into a qualitative 
study to access the acceptability of larvae therapy. 19 of those nurses had previous experience 
of larvae therapy. The majority of the nurses had no objections to using larvae therapy. Of the 
three nurses that had not used larvae therapy before two of them were reluctant to use it, stating 
they were squeamish. 
 
4.10.5 Secondary outcome results from systematic reviews 
Gray (2008) reviews the study by Wayman et al (2008) none of the above mentioned secondary 
outcome measures were reported on in this study. 
 
4.11 Summary 
From the search strategy a total of thirty-six full text articles were read, from this twenty-two 
articles were excluded.  Which left fourteen articles to include in the review. Three were RCT’s, 
four retrospective, five prospective, one observational and one systematic review.  Five studies 
included individuals with diabetic foot ulcers, five studies included individuals with leg ulcers, 
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two studies included patients with pressure ulcers, one study included patients with either 
diabetic foot ulcers or pressure ulcers and one systematic review included individuals with leg 
ulcers.  Four studies compared larvae therapy to hydrogel, four studies compare larvae therapy 
to conventional methods of debridement and six studies had no comparator to larvae therapy.  
The geographical location of the studies varied from the USA, Europe, Jerusalem, Egypt to 
Malaysia. All of the studies were critically appraised, the mean of the thirteen critically 
appraised studies was 73.45%.  The study settings were set in a variety of locations, healthcare 
centres, out patients’ clinics, in hospital to patients’ own homes. 
 
Twelve of the fourteen studies showed that larvae therapy was a fast, effective method of 
debridement. Two of the studies found that there was no difference in rate of debridement using 
larvae therapy compared to a conventional method or a hydrogel. Of the eight studies that had 
a comparator six (75%) of the studies showed that larvae therapy was more efficient as a 
debridement method. Eight of the studies found that larvae treated showed a significant 
difference in wound healing rates.  One study found no difference and five studies did not 
report wound healing rates. In ten of the fourteen studies patients who received larvae therapy 
complained of pain, the majority of this pain was mild and relieved by analgesia. One study 
reported health related quality of life and four studies reported on acceptability of larvae 
therapy, stating that patients’ were more accepting of larvae therapy in general than staff. 
 
4.12 Conclusion 
Larvae therapy is a fast effective and safe form of debridement. There is relatively little side 
effects with low reports of pain. Health related quality of life does not change from 
conventional methods with larvae therapy and has a high acceptability rate amongst patients. 
79 
 
Chapter 5: Discussion 
 
5.1 Introduction 
This chapter will begin with a summary of the findings in this systematic review.  The quality 
of the studies included will also be reviewed.  This will be followed by a discussion of the 
outcomes of the review.  The strengths and limitations of the review will be presented, 
including the potential contribution of the review.  Finally, a summary and conclusion will be 
provided. 
 
5.2 Summary of key findings in this Systematic Review 
The following are key findings of this review: 
 Larvae therapy is a fast, effective and safe method of debridement 
 Effective debridement contributes to wound healing 
 Debridement rates of larvae therapy were higher in the studies that had compared larvae 
with conventional treatments 
 There was no significant difference in overall complete healing rates between larvae 
therapy and conventional treatments 
 The main adverse effect of larvae was pain.  Only one study (Dumville et al 2009) 
reported outcomes regarding health related quality of life and there was no difference 
between the larvae group and the hydrogel group 
 Two studies (Tantawi et al 2007 & Paul et al 2009) reported that most patients’ were 
willing to try larvae therapy 
 One study (Dumville et al 2009) discussed that the majority of patients and nurses were 
accepting of larvae therapy 
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5.3 Quality of Included Studies 
The quality of studies that are included in a systematic review will ultimately reflect on the 
quality of the systematic review.  The design of the study also impacts on the quality of a study 
which in turn will impact the validity of the systematic review (CRD, 2008).  Some study 
designs are more reliable and trustworthy than others, if they are conducted correctly for 
example RCT’s.  A prospective study design (for example an RCT) is regarded as being more 
reliable than a retrospective study, as a prospective study seeks information from the future, it 
gathers information as it happens (CRD, 2008) for example the development of a disease.  A 
retrospective study relies on information from the past. There was one systematic review (Gray, 
2008) and thirteen quantitative studies in this systematic review overall, three RCT’s (Dumville 
et al 2009, Opletalova et al 2012 and Mudge et al 2014), four retrospective studies 
(Mumcuoglu et al 1998, Sherman, 2002, Sherman, 2003 and Wang et al 2010), five prospective 
studies (Sherman et al 1995, Courtenay et al 2000, Tantawi et al 2007, Jarczyk et al 2008 and 
Paul et al 2009), one observational study (Wollina et al 2002). 
 
5.4 Sampling 
Sampling is an important and necessary method used while conducting research as it reflects 
on a set target population (Kadam & Bhalerao, 2010).  Seven studies had a small sample size 
(Sherman 1995, Mumcuoglu et al 1998, Wollina et al 2002, Sherman 2003, Tantawi et al 2007, 
Jarczyk et al 2008 and Paul et al 2009).  Three studies had adequate sample size (Courtenay et 
al 2000, Paul et al 2009 and Mudge et al 2014) and three studies had large sample size 
(Sherman 2002, Dumville et al 2009, Opletalova et al 2012).  If the sample size of a study is a 
too small, the results of the study will not give a true reflection the overall target population 
(Kadam & Bhalerao, 2010).  However, if the sample size is too large more participants are put 
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at risk of the intervention rendering the study unethical (Kadam & Bhalerao, 2010).  Therefore 
it is important that a correct sample size is obtained to reflect the target population in question 
and to distinguish a statistically significant difference if one exists (Watson et al 2008).  In 
order to distinguish statistically significant difference in a study a power analysis is necessary 
(Watson et al 2008).  Statistical significant difference means the chance of the respected 
outcome occurring randomly is smaller than the agreed measure of probability, usually 0.05; 
this is usually referred to as the p value (Goodman & Gilchrist, 2013).  The p value for the 
diabetic foot group in Wang et al (2010) study was 0.00001 and CI 95%; in the pressure ulcer 
group p=0.0001 and CI 95%.  This means that there is 95% chance of finding a difference 
between each group, if a difference exists.  In the study by Opletalova et al (2012) p=0.80 CI 
95%, this means there is no statistically significant difference between the two groups in the 
study.  In the study by Dumville et al (2009) p = 0.008 and CI 95%, meaning this study shows 
a statistically significant difference as also seen in the study by Mudge et al (2014) p = 0.0004 
CI 95%. 
 
5.5 Randomisation 
When participants have consented to partake in a study, randomisation occurs when the 
participant is randomly assigned to either the study or the control group.  How randomisation 
occurred is also important, as it reduces the risk of selection bias; this should be reported within 
the study (Goodman & Gilchrist, 2013).  Reducing the risk of bias is achieved by allocation 
concealment, so that those allocating participants into groups should not be aware of the 
allocation sequence (Goodman & Gilchrist, 2013).  Nine studies had no mention of 
randomisation sequence (Sherman et al 1995, Mumcuoglu et al 1998, Courtenay et al 2000, 
Wollina et al 2002, Sherman 2002, Sherman 2003, Tantawi et al 2007, Jarczyk et al 2008 and 
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Paul et al 2009).  Four studies (Wang et al 2010, Dumville et al 2009, Opletalova et al 2012 
and Mudge 2014) had randomisation sequence in their respective studies.  
 
5.6 Blinding 
Blinding refers to withholding information about group allocation, from the participant and or 
the researcher.  Blinding helps to reduce bias, it helps to reduce the influence of those involved 
in the study interpreting the results (Goodman & Gilchrest, 2013).  For example, having the 
participants blinded reduces performance bias and having the researchers blinded reduces bias 
in relation to finding statistical significance between the intervention and the control groups.  
Single blinding means the participants are not informed of which group they are allocated to, 
whether it is the study group or the control group.  Double blinding occurs when the researcher 
and the participants are not aware of group allocation (Goodman & Gilchrest, 2013).  Sherman 
(2003) stated that blinding was not possible as the primary care team continued to deliver 
conventional treatment to some participants. A further nine studies had no mention of blinding 
(Sherman et al 1995, Mumcuoglu et al 1998, Courtenay et al 2000, Wollina et al 2002, 
Sherman 2002, Tantawi et al 2007, Jarczyk et al 2008, Paul et al 2009 and Wang et al 2010).  
Three studies had blinding (Dumville et al 2009, Opletalova et al 2012 and Mudge et al 2014). 
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5.7 Discussion of Outcomes 
 
5.7.1 Primary Outcome 
The primary outcome for this systematic review was to assess larvae therapy in chronic wounds 
to determine its impact on debridement.  From the analysis of the studies included it can be 
said that larvae debridement therapy is a safe, effective and fast method of debridement.  The 
majority of the studies used loose larvae, one study used bagged larvae (Opletalova et al 2012) 
and one study used both bagged and loose larvae (Dumville et al 2009).  Two studies 
(Courtenay et al 2000 and Mudge et al 2014) did not specify if the larvae were bagged or loose.  
From the Dumville et al (2009) study it can be concluded that there was no statistical significant 
difference between the bagged or loose larvae. 
 
Most of the studies used the larvae species Lucilia sericata except Paul et al (2009) who used 
the larvae of Lucilia cuprina.  Even though Paul et al’s (2009) study showed no statistical 
significant difference between larvae and conventional methods of debridement, there is not 
enough research to determine if one species of larvae is superior at debridement than another. 
 
Also, different studies placed various amounts of larvae on their wounds.  Two studies used 
five to eight larvae per cm2 (Sherman 2002 and Sherman 2003) one study used five to ten larvae 
per cm2 (Wang et al 2010), one study used eight to ten larvae per cm2 (Tantawi et al 2007) and 
two studies used ten larvae per cm2 (Jarczyk et al 2008 and Paul et al 2009).  Mumcuoglu et al 
(1998) measured the size and depth of the wound, then fifty to one thousand larvae were applied 
depending on the size of the wound.  Opletalova et al (2012) placed eighty larvae into each bag 
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used for debridement therapy.  Dumville et al (2009) calculated the amount of slough/necrotic 
tissue per wound and applied the necessary the amount of larvae, no specific figure is provided.  
Four studies do not mention the amount of larvae used (Sherman et al 1995, Courtenay et al 
2000, Wollina et al 2002 and Mudge et al 2014).  Therefore, although all studies used larvae, 
it is not clear what the optimal number of larvae is.  Thus, further research is required to 
determine the precise number of larvae to be used per cm2 of a chronic wound is. 
 
Of the six studies included with no comparator (Sherman 1995, Mumcuoglu et al 1998, 
Courtenay et al 2000, Wollina et al 2002, Tantawi et al 2007 and Jarczyk et al 2008) all studies 
reported that larvae therapy was an effective method of debridement.  Two studies (Sherman, 
2002 and Sherman, 2003) showed that larvae therapy was more effective as a debridement 
method however, no p-values were given.  Two studies (Paul et al 2009 and Opletalova et al) 
showed no statistically significant difference between larvae therapy and there comparator.  
Three studies (Dumville et al 2009, Wang et al 2010 and Mudge et al 2014) show statistically 
significant difference between larvae therapy and their comparator.  The systematic review 
(Gray, 2008) reviewed a study by Wayman et al (2000) which also showed a statistically 
significant difference between larvae and the comparator as a form of debridement in favour 
of the larvae.  Therefore, from this analysis, it is possible to say that, overall larvae therapy is 
an efficient, rapid and safe method of debridement.  
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5.7.2 Secondary Outcomes 
 
5.7.2.1. Rate of Healing 
From the included studies that reported wound reduction size or complete wound healing with 
a comparator, there was no statistically significant difference between larvae therapy and the 
comparator.  Sherman (1995) and Courtenay et al (2000) reported the wounds in their studies 
reduced greatly after debridement therapy.  Although none of these studies showed that wound 
healing rates were achieved quicker with larvae therapy, effective debridement is prerequisite 
to wound healing (Courtenay, et al 2000). 
 
5.7.2.2 Pain 
Pain was a common side effect of larvae therapy in eleven of the included studies.  Mudge et 
al (2014) was the only study to report patients dropping out of the study due to pain, however, 
at the end of the study there was no statistically significant difference in pain between the larvae 
group and the conventional group.  Two studies (Sherman 2002 and Sherman 2003) stated that 
patients complained of pain while receiving larvae therapy but they had also complained of 
pain while receiving conventional treatment.  While pain is an unwanted side effect and would 
be a concern to many, the majority of patients in the included studies had no major problems 
with pain, therefore if the larvae therapy is efficient and it is cost effective, there should not be 
a reason to discontinue larvae therapy if the pain can be relieved by analgesia.  Conversely, the 
patients included in the studies may have had pain on entering the study from an underlying 
condition or from a chronic wound. 
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5.7.2.3 Health Related Quality of Life 
Health related quality of life can be severely diminished in patients with chronic wounds (Hurd, 
2013).  Dumville et al (2009) was the only included study to report on health related quality of 
life.  Both the larvae group and the conventional group showed little difference in health related 
quality of life.  No conclusion can be made from a single study; therefore, it is clear further 
research is required regarding health related quality of life and chronic wounds. 
 
5.7.2.4 Acceptability of Larvae Therapy 
The concept of larvae therapy for many people can be daunting and therefore, in many cases is 
used a last resort (Steenvoorde et al 2005).  However from four of the studies included four 
studies (Sherman 2002, Tantawi et al 2007, Paul et al 2009 and Dumville et al 2009) patients 
were generally very accepting of larvae therapy.  On the other hand, staff could be very 
reluctant to use larvae therapy as reported in two studies (Sherman 2002 and Dumville et al 
2009).  More studies are needed on patient and staff acceptability of larvae therapy.  It could 
be suggested that if staff were trained and more familiar with larvae therapy and its benefits 
they may not be so reluctant to use them in the future. 
 
5.8 Outcomes of the Quality Appraisal 
As mentioned previously, the thirteen included studies were critically appraised using the EBL 
critical appraisal checklist (Glynn, 2006).  Studies that have yes scores of 75% or above are 
considered to be valid.  The average score for the studies included in this review was 72%.  The 
highest score was 92% (Dumville et al 2009 and Opletalova et al 2012) and the lowest score 
was 48% (Mumcuoglu et al 1998).  According to the EBL critical appraisal checklist (Glynn, 
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2006) only five of the thirteen studies (Paul et al 2009, Dumville et al 2009, Wang et al 2010, 
Opletalova et al 2012 and Mudge et al 2014) in this systematic review are considered valid.  
This has an overall impact on the quality of the results obtained in this systematic review, as 
the majority of the studies included are considered not valid.  The areas that impacted the 
studies that were not considered valid were, not clearly identifying inclusion and exclusion 
criteria (Mumcuoglu et al 1998, Wollina et al 2002, Sherman 2003 and Jarczyk et al 2008) not 
all studies state whether they obtained consent (Sherman et al 1995, Wollina et al 2002, 
Sherman 2002 and Jarczyk et al 2008) or ethical approval (Mumcuoglu et al 1998 and Jarczyk 
et al 2008); more studies had a small sample size (Sherman et al 1995, Mumcuoglu et al 1998, 
Sherman 2003, Tantawi et al 2007 and Jarczyk et al 2008)  Other studies did not clearly state 
whether those collecting data were also actively involved with the participants in the study 
(Mumcuoglu et al 1998, Courtenay et al 2000, Wollina et al 2002, Sherman 2002, Sherman 
2003, Tantawi et al 2007 and Jarczyk et al 2008), 
 
5.9 Strengths & Limitations of this Systematic Review 
This systematic review included all the necessary steps in order to conduct a systematic review.  
Appendix 37 shows a PRISMA checklist outlining what aspects the writer has included in this 
systematic review.  A detailed account of the search strategy for each database is given in the 
appendices (see appendix 1-5), so the search can be repeated.  The English language was the 
only language used in this systematic review. This could be considered as a language bias as 
other important papers regarding larvae therapy debridement written in a different language 
may have been excluded.  This writer did not have the ability or resources to translate papers 
from other languages. 
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5.10 Contributions of this Systematic Review 
The objective of this systematic review was to identify the how effective larvae debridement 
therapy is in the management of chronic wounds.  While this systematic review showed that 
larvae therapy is an effective method of debridement; it did not unearth any new evidence 
relating to larvae therapy.  Furthermore, this systematic review shows that there is a need for 
more RCT’s and systematic reviews in this area.  There is also a need for more studies in the 
areas of acceptability of larvae therapy and why it is used as a last resort.  This study shows 
that larvae therapy is an efficient method of debridement; if larvae therapy was used more 
frequently, it may prevent or reduce length of hospital stay. 
 
5.11 Summary and Conclusion 
The quality of studies included in a systematic review has an overall effect on the validity of 
the review.  In this systematic review five out of the thirteen studies were considered valid, 
therefore, the overall validity of this review is in question.  However, all of the studies and the 
one systematic review included in this systematic review, regardless of their quality show that 
larvae therapy is a safe, effective and fast method of debridement. 
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Chapter 6: Summary and Conclusion 
 
6.1 Introduction 
This chapter will summarise the overall findings in this systematic review and identify key 
areas for future research. 
 
6.2 Summary 
Chronic wounds are a condition that affects millions of people globally (Sen et al 2009).  
Chronic wounds affect six and a half a million people in the USA and costs $25 billion annually 
(Sen et al 2009).  Pressure ulcers cost the Irish state an estimate of €250 million per year 
(Gethin et al 2005).  Health related quality of life is severely impacted when suffering from a 
chronic wound; as wounds effect an individual’s ability to function both physically and 
mentally (Hurd, 2013).  Additionally, wounds also have an effect on the individual’s family 
and on their care givers (Hurd, 2013).  Wound bed preparation plays an important role in 
achieving wound healing, and debridement is one component of this process.  There are a 
number of different forms of debridement, for example autolytic debridement, surgical/sharp 
debridement, enzymatic debridement, mechanical debridement and larvae therapy 
debridement.  However, for the purpose of this systematic review, larvae therapy was 
examined.  From the studies retrieved for this systematic review it is evident that larvae therapy 
debridement offers effective and rapid debridement within minimal side effects.  Furthermore, 
effective debridement will enhance healing rates.  Even though this systematic review did not 
reveal any new evidence, it will inform healthcare professionals of the effectiveness of larvae 
therapy as a debriding agent for a chronic wound.  The main contributes of this review is in 
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collating research work already done which pinpoints the positive contribution of larvae 
therapy to wound healing as a safe effective therapy with minimal side effects. 
 
It is well documented that debridement is prerequisite for wound healing.  However, with 
regards to larvae therapy further research is required in a number of areas.  Debridement 
therapy has the ability to completely debride chronic wounds and this therapy should not have 
to be confined to hospitals; thus, more research is required of the usage of larvae therapy in the 
community setting.  Furthermore, as chronic wounds are very debilitating, more studies are 
required exploring the impact of larvae on health related quality of life.  Finally, the reluctance 
to use larvae therapy appears to be decreasing, as many patients would willing use them.  
However, healthcare staff appear less reluctant to use larvae.  Education of healthcare staff 
themselves regarding larvae therapy is necessary.  The main healthcare workers that deal with 
larvae are nurses.  Nurses need to be positive about larvae therapy; widespread larvae therapy 
cannot be expected if nurses have an aversion to it.  This is a key area for future research. 
 
6.3 Conclusion 
This systematic review shows that larvae debridement therapy is safe, fast and effective method 
of debridement; but many of these studies were not considered valid therefore care must be 
taken interpreting the results and implying interventions in a clinical setting. 
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Appendix 2: Web of Science Database Flowchart 
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Appendix 3: CINAHL Database Flowchart 
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Appendix 4: MedLine at EBSCOhost Database Flowchart 
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Appendix 5: Cochrane Library Database Flowchart 
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Appendix 6: Table of Included Studies 
 
Study  Title 
Sherman (1995) Maggot Therapy for Treating Pressure 
Ulcers in Spinal Cord Injury Patients 
Mumcuoglu et al (1998) Maggot Therapy for the Treatment of 
Diabetic Foot Ulcers 
Courtenay et al (2000) Larva therapy in wound management 
Wollina et al (2002) Biosurgery supports granulation and 
debridement in chronic wounds-clinical data 
and remittance spectrometry 
Sherman (2002) Maggot versus conservative debridement 
therapy for the treatment of pressure ulcers 
Sherman (2003) Maggot Therapy for Treating Diabetic Foot 
Ulcers Unresponsive to Conventional 
Therapy 
Tantawi et al (2007) Clinical and microbiological efficacy of 
MDT in the treatment of diabetic foot ulcers 
Jarczyk et al (2008) Use of Lucilia sericata blowfly maggots in 
the treatment of diabetic feet threatened with 
amputation 
Paul et al (2009) Maggot debridement therapy with Lucilia 
cuprina: a comparison with conventional 
debridement in diabetic foot ulcers 
Dumville et al (2009) VenUS II: a randomised controlled trial of 
larval therapy in the management of leg 
ulcers 
Wang et al (2010) Clinical research on the bio-debridement 
effect of maggot therapy for treatment of 
chronically infected lesions 
Opletalova et al (2012) Maggot Therapy for Wound Debridement 
Mudge et al (2014) A randomized controlled trial of larval 
therapy for the debridement of leg ulcers: 
Results of a multicenter, randomized, 
controlled, open, observer blind, parallel 
group study 
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Appendix 7: Table of Excluded Studies with Reasons 
 
Study  Reason for exclusion 
Zarchi & Jemec (2012) The original studies reviewed in this article 
were included in this systematic review 
Gilead et al (2012) Included wounds on thumb 
Davdov (2011) Not a research article 
Tanyuskel et al (2009) Not a research article 
Chan et al (2007) Not a research article 
Mumcuoglu et al (2009) Included wound on thumb 
Sherman (1998)  
Doerler et al  (2012) Not a research article 
Hoppe et al (2012) The original studies reviewed in this article 
were included in this systematic review 
Edwards & Stapley (2010) The original studies reviewed in this article 
were included in this systematic review 
Brin et al (2002) Not a research article 
Armstrong et al (2005) Does not include rate of debridement 
Hinchliffe et al (2008) The original studies reviewed in this article 
were included in this systematic review 
Sherman (2001) Included traumatic wounds and abscess 
Stoddard et al (1995) Not a research article 
Steenvoorde et al (2007) Includes trauma wounds 
Cambal et al (2006) Not a research article 
Boon et al (1996) Not a research article 
Gethin et al (2010) Only available in abstract form 
Bradley et al (1999) Does not include larvae therapy 
Parnes & Lagan (2007) Not a research article 
Tian (2013) The original studies reviewed in this article 
were included in this systematic review 
 
 
 
 
 
 
108 
 
Appendix 8: Critical Appraisal Checklist 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
    
Are inclusion and exclusion criteria definitively outlined?      
Is the sample size large enough for sufficiently precise 
estimates?  
    
Is the response rate large enough for sufficiently precise 
estimates?  
    
Is the choice of population bias-free?      
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
    
   
   
   
Was informed consent obtained?      
 
 Are data collection methods clearly described?      
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
    
Is the data collection instrument validated?      
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
    
Is the instrument included in the publication?      
Are questions posed clearly enough to be able to elicit 
precise answers?  
    
Were those involved in data collection not involved in 
delivering a service to the target population?  
    
 
 Is the study type / methodology utilized appropriate?      
Is there face validity?      
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
    
Was ethics approval obtained?      
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
    
Are all the results clearly outlined?      
Are confounding variables accounted for?      
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Do the conclusions accurately reflect the analysis?      
Is subset analysis a minor, rather than a major, focus of the 
article?  
    
Are suggestions provided for further areas to research?      
Is there external validity?      
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look at 
the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A  
Validity calculation: 
Section B validity calculation:  
Section C validity calculation:  
Section D validity calculation: 
 Overall validity calculation:   
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Appendix 9: Data Extraction Table 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion  
& 
Exclusion 
Criteria 
Sample Size  
& 
Randomisation 
Sequence 
       
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
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Appendix 10: PRISMA Checklist 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.   
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.   
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data synthesis.  
 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).   
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
 
 
 
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).   
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.   
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).   
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Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.   
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. 
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Appendix 11: Data Extraction for Sherman et al (1995) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Sherman et al 
1995 
USA 
Hospital setting 
Prospective 
controlled 
study. 
Quantitative 
study 
Ulcers were 
monitored 
visually and 
photographed 
every week.  
Ulcer width, 
length, 
circumference 
and surface 
were calculated 
from each 
photograph, 
using the Image 
Analyst 
software 
package.  
Wound quality 
& rate of 
healing was 
Rate of 
debridement in 
larvae therapy 
post 
conventional 
treatment for 
the treatment of 
pressure ulcers 
in spinal injury 
patients. 
Inclusion: 
pressure areas 
more than one 
month in 
duration 
Exclusion: 
Patients with 
underlying 
osteomyelitis or 
acute cellulitis 
Of the 20 
patients that 
had larvae 
therapy only 8 
were followed 
up for the first 
3-4 weeks 
while still 
receiving 
conventional 
treatment, 
therefore only 
those 8 patients 
were included 
in the final 
results.  
There was no 
mention of 
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also assessed 
each week. 
randomisation 
sequence in the 
study. 
Intervention 
 
Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
In between 
cycles of larvae 
therapy wounds 
were treated 
with sodium 
hypochlorite if 
still necrotic or 
normal saline if 
wounds were 
clean. 
One to two 
cycles of larvae 
therapy were 
applied for 1-2 
weeks. 
Pressure area 
Grade 2: 2 
Participants  
Grade 3: 3 
Participants  
Grade 4: 3 
Participants 
No of Males: 8 
No of Females: 
0 
Ages: 44-68 
Median age: 58 
Ulcer size: 5-
30cm2 
Quadriplegic:1 
Paraplegic: 7   
Blinding of 
patients or 
investigators 
was not 
possible for the 
study, with 
respect to the 
primary care 
team 
administering 
the 
conventional 
treatment.  The 
individuals who 
carried out the 
wound 
assessments 
There was no 
specific 
primary or 
secondary 
outcomes 
mentioned. 
Main object: 
debridement 
and complete 
healing of 
pressure area. 
 
The surface 
area of the 
wounds 
decreased by an 
average size of 
22% per week. 
Larvae 
debrided most 
necrotic 
wounds during 
the first week. 
Wound healing 
was more rapid 
in ulcers treated 
with larvae 
rather than 
Larvae therapy 
is an efficient 
and rapid form 
of debridement. 
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No mention of 
the amount of 
larvae used. 
were unaware 
of the type of 
treatment the 
patients were 
receiving. 
conventional 
dressings 
All ulcers were 
completely 
debrided within 
1-2 weeks 
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Appendix 12: Data Extraction Table for Mumcuoglu et al (1998) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Mumcuoglu et 
al 
1998 
Jerusalem 
One acute 
hospital, two 
geriatric 
hospitals and 
one outpatient 
clinic 
Retrospective 
Quantitative 
Wounds were 
photographed 
after each 
treatment or 
once a week, 
wound quality, 
odour and 
degree of 
patients pain 
was also 
recorded 
To evaluate 
larvae therapy 
as a 
debridement 
method  
No specific 
mention of 
inclusion and 
exclusion 
criteria.  
 
22 diabetic 
patients with 27 
foot ulcers. 
No mention of 
randomisation 
sequence but 
patients’ were 
selected for 
larvae therapy 
when all other 
methods of 
treatment both 
surgical & non-
surgical had 
failed 
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Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
22 diabetic 
patient with 27 
foot ulcers. 
Larvae therapy 
was applied 2-5 
times per week 
and were left 
on for 24-72 
hours.  
Depending on 
the size of the 
wound, the 
number of 
treatments 
varied from 1-
23, mean 12. 
Depending on 
the size and 
depth of the 
ulcer 50-1,000 
larvae were 
applied 
Diabetic foot 
ulcers 
22 patients 
Men: 22 
Women: 5 
Age: 41-95 
Mean age: 64.8 
Ulcers had 
existed for 1-48 
months, mean 
10.3 months 
No specific 
method of 
blinding or 
concealment 
was mentioned 
No specific 
outcome 
measures were 
identified, 
however rate of 
debridement 
was measured 
in the results. 
In 12 patients 
with superficial 
wounds, 
debridement 
was achieved 
after 1-4 
treatments 
within 1-8 
days.  There 
was complete 
debridement in 
18 wounds, 
significant 
debridement in 
6 wounds and 
partial 
debridement in 
2 wounds.  
There was no 
change to 1 
wound and 3 
wounds did not 
respond to 
treatment as the 
This study 
shows that 
larvae therapy 
is a successful 
method of 
debridement.  
The study did 
not mention the 
actual size of 
the wounds at 
the beginning 
or end of the 
study. 
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patients walked 
on the larvae 
and crushed 
them.  The 
malodour 
decreased in all 
wounds, 
however 6 
patients 
reported 
significant pain 
and were 
treated with 
analgesics. 
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Appendix 13: Data Extraction Table for Courtenay et al (2000) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Courtenay et al  
2000 
UK 
Nine various 
hospitals 
Prospective 
study 
Quantitative 
Data was 
collected on 
wound 
information 
before, during 
and after larvae 
therapy, on a 
data collection 
sheet which 
was based on a 
semi-structured 
interview from 
a previous 
study. 
To evaluate 
larvae therapy 
as a form of 
wound 
debridement. 
No specific 
inclusion 
criteria was 
identified. 
Exclusion: 
Ulcers that 
were close to 
large vessels or 
the brain. 
70 patients leg 
ulcers, 59 
patients 
included in 
final results. 
 
No mention of 
randomisation 
sequence. 
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Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
Larvae therapy 
was left on for 
a mean of 3 
days.  No 
further 
information on 
intervention 
was given.  No 
mention of the 
amount of 
larvae used. 
Leg ulcers 70 patients with 
leg ulcers, no 
further 
information on 
patients 
characteristics 
were disclosed 
No mention of 
blinding 
No specific 
inclusion or 
exclusion 
criteria given. 
30 ulcers were 
fully debrided, 
20 ulcers were 
partially 
debrided, there 
was no change 
to 8 ulcers and 
1 ulcer 
deteriorated. 
Area of 
granulation 
increased by 
21cm2 
Larvae therapy 
debrided the 
majority of the 
ulcers, showing 
it is effective as 
a debriding 
agent. 
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Appendix 14: Data Extraction Table for Wollina et al (2002) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Wollina et al 
2002 
Germany 
 
Observational 
Quantitative  
The wounds 
were assessed 
by means of a 
wound score, 
which 
documented the 
quality of the 
wound before 
and after larvae 
therapy.  Size 
of the wounds 
were 
documented at 
the start of the 
study 
To evaluate the 
clinical effects, 
side effects and 
the possible 
mechanisms of 
larvae therapy. 
No inclusion or 
exclusion 
criteria were 
mentioned 
30 patients with 
chronic leg 
ulcers. 
There was no 
mention of 
randomisation 
sequence 
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Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
Patients got one 
cycle of larvae 
therapy, with 
two patients 
requiring 3-4 
applications. 
The larvae 
were left insitu 
for 1-4 days. 
No mention of 
the amount of 
larvae used 
Chronic leg 
ulcers of mixed 
aetiology 
30 Patients, 
aged from 18-
89 years.  No 
mention of 
gender. 
No mention of 
blinding or 
concealment 
No specific 
primary or 
secondary 
outcomes 
identified. 
 
There was a 
significant 
improvement in 
the leg ulcer, 
the wound 
score had 
significantly 
decreased 
indicating a 
good result. 
The wound 
decreased from 
a score of 13.5-
1.8 to 6.3 to 2.7 
No indication 
of how wound 
score was 
calculated, no 
actual 
measurements 
for wounds post 
debridement 
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Appendix 15: Data Extraction Table for Sherman (2002) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Sherman 
2002 
USA 
Hospital setting 
Retrospective 
Qualitative 
Patient 
information 
was obtained 
from their 
medical chart. 
Ulcer length, 
width, 
circumference 
and surface 
area were 
calculated from 
digitized 
images and 
tracings using 
the Image 
Analyst 
software 
package. 
To determine 
the efficacy and 
safety of larvae 
therapy 
No specific 
inclusion 
criteria was 
mentioned. 
Exclusion 
criteria : 
Underlying 
osteomyelitis or 
rapidly 
advancing 
infection that 
required 
surgical 
intervention 
103 patients 
with 145 
pressure ulcer 
were initially 
evaluated, 67 
patients with 92 
wounds were 
included in the 
results.  
There was no 
mention of 
randomisation 
sequence. 
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Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
67 patients 
92 pressure 
ulcers 
Larvae 
Therapy: 43 
wounds 
Conventional 
Therapy: 49 
Patients were 
photographed 
every week and 
wound margins 
were traced 
onto on 
transparent 
acetate sheet. 
Larvae was 
applied to the 
wound for 48 
hours. Two 48 
hour cycles 
Pressure ulcers, 
Larvae therapy 
patients:  
25 had grade 3 
pressure ulcer 
18 had grade 4 
pressure ulcer 
Surface area of 
wounds ranged 
from 15.7-
28.4cm2 
(average 
22.1cm2) 
Conventional 
therapy 
patients: 
45 had grade 3 
pressure ulcer 
Gender was not 
mentioned. 
Patients’ age 
ranged from 
26-85 in the 
larvae group, 
with the mean 
age 62.  In the 
conventional 
group ages 
ranged from 
32-91, with the 
mean age 66. 
Blinding or 
concealment 
was not 
identified in 
this study 
Primary 
outcome: 
Changes in 
surface area, 
necrotic tissue 
and granulation 
tissue over 
time. 
Secondary 
outcomes: 
complete 
wound 
debridement 
and complete 
healing of the 
wound 
Larvae group 
treatment lasted 
4.1-5.5 weeks, 
average of 4.8 
weeks. 
Conventional 
group treatment 
lasted 4.9-6.2 
weeks, average 
of 5.5 weeks. 
80% of larvae 
treated wound 
were 
completely 
debrided in less 
than 5 weeks. 
52% of the 
conventional 
treated wounds 
were not 
Larvae therapy 
is an effective, 
fast & safe 
method of 
debridement 
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were applied 
each week.  
Saline or 
sodium 
hypochlorite 
moist gauze 
was applied in 
between larvae 
cycles for 1-4 
days. 
Five to eight 
larvae was used 
per cm2 
4 had grade 4 
pressure ulcer. 
Surface area of 
wounds ranged 
from 9.7-18.2 
cm2 (average 
14 cm2) 
debrided after 
5.5 weeks. 
49% of larvae 
treated wounds 
had 50% 
granulation 
tissue during 
treatment, 
whereas only 
18% of 
conventional 
treated wounds 
had 50% 
granulation 
tissue 
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Appendix 16: Data Extraction Table for Sherman (2003) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Sherman 
2003 
USA 
Hospital setting 
 Retrospective 
Quantitative 
Diabetic foot 
ulcer length, 
width, 
circumference 
and surface 
area were 
measured using 
digital 
photographic 
pictures.  The 
ulcers were 
assessed every 
week for eight 
weeks or until 
hospital 
discharge. 
To compare 
larvae therapy 
as a form of 
debridement 
with 
conventional 
methods of 
debridement. 
Inclusion and 
exclusion 
criteria was not 
disclosed, 
however 
patients that 
diabetic foot 
ulcers that were 
not responding 
to conventional 
forms of 
treatment were 
consented to 
use larvae 
therapy. 
 
Study group 
n=6 
Conventional 
group n=6 
Conventional 
and larvae 
group n=8 
Patients 
continued 
treatment for 
two weeks 
observation, if 
the wound 
didn’t improve 
larvae therapy 
was 
commenced 
128 
 
after the patient 
consented. 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
The larvae 
therapy group 
had the larvae 
changed 48 
hourly. One to 
two cycles 
were used each 
week for an 
average of 4.7 
weeks.  The 
conventional 
group had 
saline soaked 
gauze replaced 
8 hourly, 
hydrogel placed 
on the wound 
Leg ulcers Gender was not 
disclosed. 
Average age in 
the larvae 
group was 68 
years. 
Average age in 
the 
conventional 
group was 63 
years. 
Average ulcer 
size in the 
larvae group 
was 13.3cm2 
Blinding was 
not possible as 
the primary 
care team 
continued to 
deliver 
conventional 
treatment and 
those in the 
larvae group 
consented to 
using larvae 
therapy. 
Primary 
outcome 
measures were: 
1) Change in 
amount of 
necrotic tissue 
2) Change in 
granulation 
tissue 
3) Change in 
wound surface 
area 
4) length of 
time until 
Larvae therapy 
was quicker at 
debridement, 
with all ulcers 
fully debrided 
within four 
weeks and the 
conventional 
group debrided 
at five weeks. 
After two 
weeks of 
treatment the 
larvae group 
had a mean of 
7% necrotic 
These results 
show that 
larvae therapy 
is a fast 
effective and 
safe method of 
debridement. 
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three times 
daily or 
surgical 
debridement. 
5-8 larvae were 
used per cm2 
Average ulcer 
size in the 
conventional 
group was 
8.4cm2 
complete 
healing 
Secondary 
outcomes were 
not clarified 
tissue (pre-
treatment 38%) 
and the 
conventional 
group had 39% 
necrotic tissue 
(pre-treatment 
44%) 
Granulation 
tissue pre-
treatment: 
Larvae group: 
19% 
Conventional 
group: 18% 
Granulation 
tissue post-
treatment: 
Larvae group: 
56% 
Conventional 
group: 15% 
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Appendix 17: Data Extraction Table for Tantawi et al (2007) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Tantawi et al 
2007 
Egypt 
Hospital setting 
 Prospective 
Quantitative 
Wound 
histories and 
previous 
treatments were 
obtained from 
patients 
medical charts.  
Diabetic foot 
ulcers were 
classified using 
the University 
of Texas 
classification 
system.  
Ischemia was 
detected by 
absent pedal 
pulses.  Clinical 
signs of 
To determine 
the clinical and 
microbiological 
effect of larvae 
therapy in 
diabetic foot 
ulcers 
unresponsive to 
surgical and 
non-surgical 
conventional 
treatment 
Inclusion 
criteria: 
diabetic foot 
ulcer that was 
necrotic and 
sloughy 
Exclusion 
criteria: Life-
threatening 
illness or 
patients with 
rapidly 
increasing 
infection that 
required 
surgical 
intervention 
10 patients with 
13 diabetic foot 
ulcers. 
No mention of 
randomisation 
sequence 
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infection were 
also recorded 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
Larvae was 
applied to 
ulcers for 3 
days a week, 
until full 
debridement 
had occurred. 
When full 
debridement 
has occurred 
saline soaked 
gauze was 
placed on the 
wound until 
completely 
healed.  
Patients were 
Diabetic foot 
ulcers. 
10 patients 
Female:7  
Male: 3 
Age of patients 
ranged from 
31-60 years, 
mean 53.3 
years 
The surface 
area of the 
wounds at 
baseline ranged 
from 1.3-
63.1cm2, the 
No mention of 
blinding or 
concealment 
Primary 
outcomes were: 
Change in ulcer 
surface area 
and percentage 
of necrotic 
tissue, amount 
of time to 
achieve 
complete 
debridement 
and complete 
healing, the 
change in 
bacterial 
burden during 
After larvae 
therapy the 
wound surface 
area had 
decreased from 
23.5cm2 to 
2.3cm2 in a 
mean of 8.1 
weeks.   
Complete 
debridement of 
all ulcers had 
occurred in a 
mean of 1.9 
weeks (range1-
4 weeks).  
This study 
shows that 
larvae therapy 
is sufficient at 
debriding 
diabetic foot 
ulcers rapidly 
and reduces 
bacterial 
burden. 
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followed up for 
a total of 12 
weeks. 
Swabs were 
taken before 
and after each 
larvae therapy 
application 
8-10 larvae 
were applied 
per cm2 
mean was 
23.5cm2 
Necrotic tissue 
ranged from 
29.9-100% of 
the ulcer, mean 
was 74.9%  
larvae 
treatment 
Two ulcers did 
not heal 
completely but 
decreased by 
up to 30% in 
size.  None of 
the patients 
complained of 
pain. 
Bacterial 
burden 
decreased 
significantly 
after larvae 
therapy 
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Appendix 18: Data Extraction Table for Jarczyk et al (2008) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Jarczyk et al  
2008 
Torun, Poland. 
 
Hospital setting 
Prospective 
Quantitative 
Photographic 
documentation 
was obtained 
before and after 
larvae therapy 
To evaluate the 
efficiency of 
larvae therapy 
on diabetic 
ulcers that are 
at risk of 
amputation 
Inclusion and 
exclusion 
criteria not 
included 
4 patients with 
diabetic foot 
ulcers. 
 
No mention of 
randomisation 
sequence 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
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Larvae were 
placed on the 
wound for 2-3 
days. 
Before and 
after larvae 
treatment 
swabs were 
taken of the 
wound. 
The duration of 
therapy lasted 
between 9-18 
days (mean 12 
days). 
10 larvae per 
cm2 
Diabetic foot 
wound 
Surface area of 
wound range: 
19-139cm2, 
mean 47cm2 
4 patients. 
Female: 1 
Male: 3 
Age:56-75, 
Mean age: 63 
Ulcers present 
for 2-9 months 
prior to larvae 
therapy, mean 5 
months. 
No mention of 
blinding or 
concealment 
No specific 
primary or 
secondary 
outcome 
mentioned. 
One patient had 
unsuccessful 
debridement 
and was 
subjected to 
limb 
amputation.  2nd 
patient 
complete 
debridement 
but had two 
digits 
amputated. The 
other two 
patients 
achieved 
complete 
debridement & 
avoided 
amputation. 
This shows that 
larvae is 
successful for 
debridement, 
but sample size 
too small. 
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Appendix 19: Data Extraction Table for Paul et al (2009) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Paul et al 
2009 
Malaysia 
Hospital setting 
 Prospective 
case-control 
study 
Quantitative 
Outcome 
scoring system 
devised to 
assess wound at 
end of study 
To assess how 
effect larvae 
therapy is for 
the treatment of 
diabetic foot 
ulcers. 
Inclusion 
criteria: All 
patients aged 
35-70 years in 
orthopaedic 
ward who were 
admitted with 
diabetic foot 
ulcer, below the 
ankle. 
Exclusion 
criteria: 
Gangrenous 
wounds, 
necrotising 
fasciitis, 
wounds with 
exposed 
29 patients in 
the study group 
were treated 
with larvae, 4 
patients stopped 
larvae treatment 
(2 due to pain, 
1 self-
discharged, 1 
had surgery on 
the other leg) 
25 patients in 
the study group 
were included 
in the results. 
30 patients in 
the control 
group had 
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tendons/bones, 
abscesses, 
bleeding 
wounds, ABPI 
less than 0.75, 
patients are 
entomophobic. 
conventional 
treatment.  1 
patient self-
discharged, 
therefore was 
excluded from 
the results.  29 
patients were 
included in the 
final results.   
No mention of 
randomisation 
sequence. 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
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For the study 
group larvae 
was placed on 
the wound for 
48 hours, larvae 
were re-applied 
where required.  
If no 
improvement 
after 3 cycles, 
larvae therapy 
was stopped 
and another 
form of 
debridement 
was carried out. 
For the control 
group, wounds 
were daily 
dressed with 
normal saline, 
surgical 
debridement 
was performed 
as required. 
10 larvae per 
cm2 
Diabetic foot 
wound, below 
the ankle 
There were 29 
patients in the 
study group 
Male: 18 
Female: 11 
Age: 30-70 
years, mean 
56.6 years (4 of 
these patient 
did not 
complete the 
study) 
There were 30 
patients in the 
control group. 
Male:20 
Females: 10 
Age: 32-82.5, 
mean 55.6 
years (1 of 
these patients 
did not 
complete the 
study) 
 
No mention of 
blinding or 
concealment. 
There was no 
specific 
primary or 
secondary 
outcomes.  For 
the outcome 
measurements, 
a wound 
outcome 
scoring system 
was devised, 
one for each 
group.  The 
scoring system 
had the 
categories, 
healed, 
unhealed or 
others- which 
were further 
sub-divided for 
each group. 
There was no 
significant 
difference in 
rate of 
debridement or 
wound healing.  
There was no 
difference to 
bacterial load. 
The Lucilia 
cuprina larvae 
was used for 
this study, 
which is readily 
available in a 
tropical 
country, 
however is not 
normally used 
for debridement 
in the western 
world. This 
study showed 
that larvae is 
acceptable to 
use for diabetic 
foot ulcers, but 
does not show a 
significant 
difference. 
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Appendix 20: Data Extraction Table for Dumville et al (2009) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion  
& 
Exclusion Criteria 
Sample Size  
& 
Randomisation 
Sequence 
Dumville et al 
2009 
Community 
services, 
outpatient and 
community leg 
ulcer clinics, 
UK 
Three armed 
RCT 
Study type: 
Quantitative 
Leg ulcer area 
was measured 
using acetate 
tracings with 
marked grid of 
1cm2 squares 
and a marker.  
Ulcers were put 
into groups of 
equal to or less 
than 5cm2 or 
greater than 
5cm2  
Digital 
photographs 
were also taken 
and the position 
To compare 
loose and 
bagged larvae 
therapy with 
hydrogel as a 
form of 
debridement 
and wound 
healing method 
Inclusion: 
sloughy/necrotic leg 
ulcer that covered at 
least 25% of the 
wound, ABPI of 0.6 
or more, care would 
be received in 
community/outpatient, 
non-healing ulcer 
<5cm2 or >5cm2, over 
18 years old and were 
able to give written 
consent. 
Exclusion: Currently 
in another trial 
regarding leg ulcers, 
had previously been in 
the trial, women of 
267 patients 
 
Loose larvae:94 
Bagged 
larvae:86 
Hydrogel:87 
Randomisation: 
Participants 
were 
randomised by 
centre and ulcer 
area into one of 
the three arms.  
Allocation 
concealment 
was ensured by 
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of ulcers was 
also recorded 
child bearing 
potential, pregnant or 
lactating, allergic to 
any of the dressings 
being used and were 
on anti-coagulants 
the 
randomisation 
sequence being 
carried out by 
an independent 
via telephone. 
Intervention  
 
Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
The loose and 
bagged groups 
had larvae 
placed on the 
ulcers with a 
secondary 
dressing 
covering the 
larvae and left 
insitu for 3-4 
days 
In the third 
group, hydrogel 
was placed on 
the ulcers and 
covered with a 
Venous leg 
ulcers and 
mixed aetiology 
(venous/arterial) 
leg ulcers  
Median ulcer 
size:  
Loose larvae 
group: 17.3cm2 
Bagged larvae 
group: 12.2cm2 
Hydrogel 
group: 12.2cm2 
Aged: 20-94 
years 
Mean age: 74 
years 
Female: 158 
Male: 109 
Mean ABPI:1.0 
Range of 
ABPI: 0.6-2.1 
 
Concealment 
was ensured by 
randomisation 
being 
completed by 
an independent 
via telephone 
Primary 
Outcome: 
complete ulcer 
healing. 
Secondary 
outcomes: ulcer 
debridement, 
health-related 
quality of life, 
bacterial load, 
pain, cost of 
treatment and 
staff & patient 
perception 
towards larvae 
therapy 
No difference was 
shown in healing time 
between either of the 
larvae groups. 
No difference was 
shown in healing 
times between both 
larvae groups together 
and the hydrogel 
group. 
The ulcers treated 
with the larvae were 
debrided significantly 
faster than the ulcers 
treated with hydrogel. 
There was no 
significant 
difference in 
healing times 
between larvae 
and hydrogel. 
There was a 
statistically 
significant 
difference 
between larvae 
and hydrogel in 
regards rate of 
debridement. 
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secondary 
dressing and 
changed 
according to 
the nurse 
attending to the 
wound 
 
When neither 
larvae nor 
hydrogel were 
being used the 
patients with 
ABPI >0.8were 
offered 4 
layered 
compression 
bandage, 
patients with 
ABPI greater 
than or equal 
0.6 to 0.8 were 
offered 3 
layered 
bandage. 
The amount of 
slough per 
wound was 
calculated and 
There was no 
difference in rate of 
debridement between 
either of the larvae 
groups. 
There was no 
difference in bacterial 
load or health-related 
quality of life in any 
of the groups. 
There was a 
significant amount of 
pain in the ulcers 
treated with larvae 
than hydrogel. 
All treatments had 
similar costs 
The average time for 
debridement in the 
loose larvae group 
was 11.95 days, in the 
bagged larvae group 
12.84 days and in the 
hydrogel group 43.17 
days 
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the required no. 
of larvae was 
used. 
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Appendix 21: Data Extraction Table for Wang et al (2010) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Wang et al  
2010 
China 
Hospital setting 
A retrospective 
study 
Quantitative 
 
Wounds were 
monitored 
every day, how 
the data was 
collected is not 
provided 
To evaluate the 
effect of larvae 
therapy for 
treating chronic 
wounds 
No specific 
inclusion 
criteria were 
met. 
Exclusion 
criteria: 
positive blood 
cultures, 
symptoms of 
systematic 
infection and 
gangrene in the 
area of the 
wound. 
43 patients 
included in the 
study.  25 
patients had 
diabetic foot 
ulcers and 18 
patients had 
pressure ulcers. 
Randomisation 
sequence: 
Patients that 
were willing to 
agree to larvae 
therapy were 
put in the study 
group (23) and 
patients who 
did not want 
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larvae therapy 
were put in the 
control group 
(20). 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
Larvae were 
changed every 
day and the 
wound 
examined.  This 
continued until 
the wound 
healed. 
The control 
group had their 
dressing 
changed every 
day, they were 
dressed with 
normal saline 
and surgical 
Diabetic foot 
ulcers: 25 
patients, 12 in 
the control 
group and 13 in 
the study 
group. 
Pressure ulcers: 
18 patients, 8 in 
the control 
group and 10 in 
the study group 
Wound area 
ranged from 7-
45cm2. 
43 patients 
Male: 29 
Female: 14 
Age: ranged 
from 32-60 
 
No mention of 
blinding or 
concealment  
No primary or 
secondary 
outcomes were 
clearly defined. 
Diabetic foot 
ulcer patients: 
All wounds 
healed 
completely. 
The mean time 
to complete 
debridement 
was 3.1 days in 
the study 
group, where in 
the control 
group it was 
6.3 days. 
The mean time 
to complete 
Larvae therapy 
is a fast effect 
& safe method 
for complete 
debridement. 
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debrided if 
required.  
5-10 larvae 
used per cm2 
healing for the 
study group 
was 26.4 days, 
the control 
group was 39.6 
days. 
Pressure ulcer 
patients: 
All wounds 
completely 
healed.  The 
mean time to 
complete 
debridement 
was 2.5 days on 
the study group 
and 4.8 days in 
the control 
group.  The 
mean time to 
complete 
healing in the 
study group 
was 18.7 days, 
in the control 
group was 30.6 
days. 
All patients 
were followed 
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up for 3.5 to 6 
months, none 
of the ulcers 
had re-
occurred. 
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Appendix 22: Data Extraction Table for Opletalova et al (2010) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Opletalova et al 
2012 
Caen & Lyon, 
France 
2x Hospital 
setting 
 A randomized 
controlled 
multicentre trial 
Quantitative  
Clinical 
evaluation on 
day 1, 8, 15 and 
30 including 
wound surface 
area, 
percentage of 
slough and 
pain. 
Photographs 
were taken on 
these days by a 
blind assessor 
To examine 
how efficient 
larvae therapy 
is for wound 
debridement 
versus 
conventional 
treatment 
Inclusion 
criteria: non-
healing sloughy 
venous ulcer of 
40cm2 or less 
on the lower 
limb. ABPI of 
0.8 or higher. 
Exclusion 
criteria: 
pregnancy or 
lactation, 
neuropathy 
and/or 
perforated ulcer 
of the foot, 
dementia or 
previous 
119 patients 
were 
randomised for 
inclusion, 105 
were included 
in the final 
results. 
Randomisation 
sequence: 
Patients were 
randomised into 
each group 
using a 
randomisation 
list which faxed 
the names of 
patients for 
each group to 
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hospitalization 
for non-healing 
wound. 
the study 
centre. 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
The larvae 
group had their 
larvae changed 
twice a week.  
The control 
group had their 
wounds 
surgically 
debrided 3 
times a week, 
then had 
hydrogel 
dressing on dry 
wounds and 
alginate 
dressing on 
Venous ulcers. 
40cm2 or 
smaller 
105 patients 
Male: 45 
Female: 60 
Larvae group: 
51 
Control group: 
54 
Patients’ were 
blind folded 
during dressing 
changes so they 
did not know 
which type of 
dressing they 
were receiving.   
At the end of 
the study all of 
the photographs 
were assessed 
by a nurse who 
had no input in 
the patients’ 
treatment. 
The primary 
outcome was to 
assess the 
percentage of 
slough on the 
larvae group 
versus the 
control group 
on day 15  
There was no 
significant 
difference in 
percentage of 
wound slough 
between the 
two groups on 
day 1, 15 & 30.  
However, on 
day 8 there was 
a significant 
difference 
between the 
larvae group 
(mean slough 
54.5%) and the 
control group 
During the first 
week of 
treatment larvae 
was much faster 
at debridement 
than the control 
group.  
However there 
was no 
difference in 
overall healing 
rates. 
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sloughy 
wounds. 
All patients in 
both groups 
were 
discharged 
home on day 15 
with 
hydrocolloid, 
hydrocellular or 
alginate 
dressings and 
were followed 
up on day 30. 
80 larvae were 
used in each 
bag. 
(mean slough 
66.5%).  There 
was no 
significant 
difference from 
day 8 to 30 in 
healing rates in 
either group.  
Mild pain was 
experienced in 
both groups. 
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Appendix 23: Data Extraction Table for Mudge et al (2014) 
 
Author(s) 
& Date of 
Publication 
Geographical 
Location, 
& Health Care 
Setting 
Design 
& 
Study Type 
Data 
Collection 
Research 
Question 
Aim 
Objective 
Inclusion & 
Exclusion 
Criteria 
Sample Size 
& 
Randomisation 
Sequence 
 
Mudge et al  
2014 
UK 
Hospital, 
community, 
nursing home, 
research clinic 
setting and 
patients’ own 
home. 
 A randomized 
control trial 
Quantitative 
Leg ulcers were 
reviewed every 
3-4 days until 
debridement or 
21 days.  
Photographs 
were taken, 
surrounding 
skin assessed.  
Wounds were 
also reviewed 
7-14 days after 
last study visit- 
final evaluation 
Photographs 
were also taken 
at the final 
assessment. 
To compare the 
effectiveness of 
larvae therapy 
with hydrogel 
in terms of 
debridement 
Inclusion: 
Venous leg 
ulcer or mixed 
aetiology ulcer, 
ABPI equal or 
greater than 0.5, 
25% 
necrotic/sloughy 
wound. 
No mention of 
exclusion 
criteria. 
Sample size 
was based on 
data from a 
previous study. 
88 patients 
were included 
in the study, 64 
patients were 
included in the 
final results, 
larvae n=32 and 
hydrogel n=32 
 
Randomisation 
was stratified 
by size.  An 
ulcer with 25% 
slough/necrotic 
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tissue, greater 
than or equal to 
2cm2  and at 
least 5cm from 
any other ulcer. 
Intervention  Type of 
Wound 
Patient 
Characteristic 
Blinding Outcome 
Measures 
Results Conclusion 
All wound 
were cleansed 
with saline and 
sudocrem 
applied to the 
wound edges. 
Larvae was 
applied to 46 
patients’ 
wounds. 
Hydrogel 
applied to 42 
wounds. 
All wounds 
were then 
Venous and 
mixed 
aetiology leg 
ulcers. 
88 patients in 
total. 
Male: 38 
Female: 50 
The wounds 
were assessed 
by blinded 
assessors to 
determine rate 
of debridement. 
No specific 
primary or 
secondary 
outcomes were 
mentioned 
67.4% of the 
larvae debrided 
ulcers were 
fully debrided 
by within the 21 
day phase, 
26.2% from the 
hydrogel control 
group were fully 
debrided. 
Patients in the 
larvae group 
complained of 
more pain than 
those in the 
control group. 
This study 
shows that 
larvae is a fast 
effective form 
of debridement. 
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covered in a 
simple bandage 
and 
compression 
therapy. 
Wounds were 
review every 3-
4 days until 
debridement 
was complete 
or up to 21 
days. 
 
The ulcers were 
fully assessed 7-
14 days after 
study 
completion, 
29% of the 
larvae group 
remained 
debrided, 
whereas 73% of 
the control 
group remained 
debrided 
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Appendix 24: Critical Appraisal Checklist for Sherman et al (1995) 
EBL Critical Appraisal Checklist  Yes  
(Y)  
 No  
(N)  
 Unclear 
(U)  
N/A  
 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study?  
Y       
Are inclusion and exclusion criteria definitively outlined?  Y      
Is the sample size large enough for sufficiently precise 
estimates?  
  N     
Is the response rate large enough for sufficiently precise 
estimates?  
       N/A 
Is the choice of population bias-free?  Y       
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
       N/A 
      
      
      
Was informed consent obtained?      U   
 
 Are data collection methods clearly described?  Y       
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
      N/A 
Is the data collection instrument validated?      U   
If based on regularly collected statistics, are the statistics free 
from subjectivity?  
Y       
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect?  
Y       
Is the instrument included in the publication?  Y       
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y       
Were those involved in data collection not involved in 
delivering a service to the target population?  
    U   
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of detail 
that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?  Y    
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?   N   
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look 
at the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can safely 
conclude that the study is valid.  
  
Section A validity calculation:  Y=60% 
Section B validity calculation: Y=71% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=67% 
 Overall validity calculation:   
Y=17/23=74% 
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Appendix 25: Critical Appraisal Checklist for Mumcuoglu et al (1998) 
EBL Critical Appraisal Checklist  Yes  
(Y)  
 No  
(N)  
 Unclear 
(U)  
N/A  
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?   N   
Is the sample size large enough for sufficiently precise 
estimates?  
 N   
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
   N/A 
   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?   N   
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?    U  
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
  U  
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
  U  
Was ethics approval obtained?    U  
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?   N   
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?   N   
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look at 
the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=60% 
Section B validity calculation: Y=29% 
Section C validity calculation: Y=60% 
Section D validity calculation: Y=50% 
 Overall validity calculation:   
Y=11/23=48% 
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Appendix 26: Critical Appraisal Checklist for Courtenay et al (2002) 
EBL Critical Appraisal Checklist  Yes  
(Y)  
 No  
(N)  
 Unclear 
(U)  
N/A  
 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?  Y    
Is the sample size large enough for sufficiently precise 
estimates?  
Y    
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
 N  
   
 N  
Was informed consent obtained?    U  
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?    U  
If based on regularly collected statistics, are the statistics free 
from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of detail 
that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look 
at the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can safely 
conclude that the study is valid.  
  
Section A validity calculation:  Y=63% 
Section B validity calculation: Y=57% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=67% 
 Overall validity calculation:  
Y=18/26=69%  
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Appendix 27: Critical Appraisal Checklist for Wollina et al (2002) 
EBL Critical Appraisal Checklist  Yes  
(Y)  
 No  
(N)  
 Unclear 
(U)  
N/A  
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?   N   
Is the sample size large enough for sufficiently precise 
estimates?  
   N/A 
Is the response rate large enough for sufficiently precise 
estimates?  
Y    
Is the choice of population bias-free?     N/A 
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
    
   
   
   
Was informed consent obtained?    U  
 
 Are data collection methods clearly described?   N   
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?   N   
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
   N/A 
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
  U  
Was ethics approval obtained?    U  
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?   N   
Is there external validity?  Y    
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look at 
the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=67% 
Section B validity calculation: Y=33% 
Section C validity calculation: Y=50% 
Section D validity calculation: Y=67% 
 Overall validity calculation:   
Y=11/21=52% 
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Appendix 28: Critical Appraisal Checklist for Sherman (2002) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual and 
eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?  Y    
Is the sample size large enough for sufficiently precise 
estimates?  
Y    
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
 N  
   
 N  
Was informed consent obtained?    U  
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?    U  
If based on regularly collected statistics, are the statistics free 
from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate for 
capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of detail 
that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look 
at the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can safely 
conclude that the study is valid.  
  
Section A validity calculation:  Y=63% 
Section B validity calculation: Y=57% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=67% 
 Overall validity calculation:   
Y=18/26=69% 
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Appendix 29: Critical Appraisal Checklist for Sherman (2003) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
 N   
Are inclusion and exclusion criteria definitively outlined?   N   
Is the sample size large enough for sufficiently precise 
estimates?  
 N   
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
Y   
   
 N  
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?  Y    
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?  Y    
Are questions posed clearly enough to be able to elicit 
precise answers?  
   N/A 
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?   N   
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    N  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s 
validity is questionable.  It is important to look at 
the overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=50% 
Section B validity calculation: Y=83% 
Section C validity calculation: Y=80 
Section D validity calculation: Y=66.6% 
 Overall validity calculation:   
Y=17/25=68% 
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Appendix 30: Critical Appraisal Checklist for Tantawi et al (2007) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?  Y    
Is the sample size large enough for sufficiently precise 
estimates?  
 N   
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
   N/A 
   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?  Y    
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?   N   
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?   N   
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=80% 
Section B validity calculation: Y=71% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=50% 
 Overall validity calculation:   
Y=17/23=74% 
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Appendix 31: Critical Appraisal Checklist for Jarczyk et al (2008) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?   N   
Is the sample size large enough for sufficiently precise 
estimates?  
 N   
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
   N/A 
   
   
   
Was informed consent obtained?    U  
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?  Y    
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?    U  
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?    U  
Is there external validity?    U  
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=40% 
Section B validity calculation: Y=86% 
Section C validity calculation: Y=80% 
Section D validity calculation: Y=50% 
 Overall validity calculation:   
Y15/23%=65% 
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Appendix 32: Critical Appraisal Checklist for Paul et al (2009) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?  Y    
Is the sample size large enough for sufficiently precise 
estimates?  
  U  
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
   N/A 
   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?    U  
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
  U  
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?  Y    
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?  Y    
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=80% 
Section B validity calculation: Y=57% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=83% 
 Overall validity calculation:   
Y=18/23=78% 
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Appendix 33: Critical Appraisal Checklist for Dumville et al (2009) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?  Y    
Is the sample size large enough for sufficiently precise 
estimates?  
Y    
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
Y   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?  Y    
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?  Y    
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
    
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?    U  
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=100% 
Section B validity calculation: Y=100% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=67% 
 Overall validity calculation:   
Y=23/25=92% 
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Appendix 34: Critical Appraisal Checklist for Wang et al (2010) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?   N   
Is the sample size large enough for sufficiently precise 
estimates?  
Y    
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
Y   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?    U  
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?    U  
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=86% 
Section B validity calculation: Y=57% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=67% 
 Overall validity calculation:   
Y=19/25=76% 
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Appendix 35: Critical Appraisal Checklist for Opletalova et al (2012) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?  Y    
Is the sample size large enough for sufficiently precise 
estimates?  
Y    
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
Y   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?  Y    
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?  Y    
Are questions posed clearly enough to be able to elicit 
precise answers?  
   N/A 
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?  N    
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=100% 
Section B validity calculation: Y=83% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=100% 
 Overall validity calculation:   
Y=22/24=92% 
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Appendix 36: Critical Appraisal Checklist for Mudge et al (2014) 
EBL Critical Appraisal Checklist  Yes 
(Y) 
 No 
(N) 
 Unclear 
(U) 
N/A 
 
 Is the study population representative of all users, actual 
and eligible, who might be included in the study?  
Y    
Are inclusion and exclusion criteria definitively outlined?   N   
Is the sample size large enough for sufficiently precise 
estimates?  
Y    
Is the response rate large enough for sufficiently precise 
estimates?  
   N/A 
Is the choice of population bias-free?  Y    
If a comparative study:  
Were participants randomized into groups?  
Were the groups comparable at baseline?  
If groups were not comparable at baseline, was 
incomparability addressed by the authors in the analysis?  
Y    
Y   
   
   
Was informed consent obtained?  Y    
 
 Are data collection methods clearly described?  Y    
If a face-to-face survey, were inter-observer and intra-
observer bias reduced?  
   N/A 
Is the data collection instrument validated?    U  
If based on regularly collected statistics, are the statistics 
free from subjectivity?  
Y    
Does the study measure the outcome at a time appropriate 
for capturing the intervention’s effect?  
Y    
Is the instrument included in the publication?  Y    
Are questions posed clearly enough to be able to elicit 
precise answers?  
Y    
Were those involved in data collection not involved in 
delivering a service to the target population?  
  U  
 
 Is the study type / methodology utilized appropriate?  Y    
Is there face validity?  Y    
Is the research methodology clearly stated at a level of 
detail that would allow its replication?  
Y    
Was ethics approval obtained?  Y    
Are the outcomes clearly stated and discussed in relation to 
the data collection?  
Y    
Are all the results clearly outlined?  Y    
Are confounding variables accounted for?    U  
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Do the conclusions accurately reflect the analysis?  Y    
Is subset analysis a minor, rather than a major, focus of the 
article?  
Y    
Are suggestions provided for further areas to research?  Y    
Is there external validity?   N   
Calculation for section validity:  (Y+N+U=T)  
  
If Y/T <75% or if N+U/T > 25% then you can 
safely conclude that the section identifies 
significant omissions and that the study’s validity 
is questionable.  It is important to look at the 
overall validity as well as section validity.  
Calculation for overall validity:  (Y+N+U=T)  
  
If Y/T ≥75% or if N+U/T ≤ 25% then you can 
safely conclude that the study is valid.  
  
Section A validity calculation:  Y=86% 
Section B validity calculation: Y=71% 
Section C validity calculation: Y=100% 
Section D validity calculation: Y=67% 
 Overall validity calculation:   
Y=20/25=80% 
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Appendix 37: PRISMA Checklist for Gray (2008) 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  X 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
378 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  378 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
379-382 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
X 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
379 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
379 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
379 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
379 
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
X 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
379 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data synthesis.  
X 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  X 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
X 
 
 
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
X 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
X 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
380 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
380 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  X 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
380 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  X 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  X 
180 
 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
X 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
380 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
379-382 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
382-383 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review.  
X 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. 
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Appendix 38: PRISMA Checklist for this systematic Review 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Cover 
Page 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
10 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  17 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
40 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
X 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
40 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
41 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
49 & 
Appendix 
1-5 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
28 
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Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
42 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
40 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data synthesis.  
81-82 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  59-69 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
66-67 
 
 
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
X 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
85-86 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
46 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up 
period) and provide the citations.  
49-58 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  X 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
59-69 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  66-67 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  X 
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Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
85-86 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
83-84 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
87 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  89-90 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
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Appendix 39: Timescale 
Systematic          
Review 
Oct Nov Dec Jan Feb March April May June 
Research Question   
 
       
Search Databases   
 
       
Chapter 1 Background   
 
       
Chapter 2 
Methodological Issues 
  
 
       
Data Extraction   
 
       
Data Analysis   
 
       
Chapter on Results   
 
       
Chapter on Discussion 
of Results 
  
 
       
Chapter on Summary 
and Conclusion 
  
 
       
Submit Thesis   
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Appendix 40: Resources 
 
Articles from library: €20 
 
Printing:                      €200 
 
Stationary:                  €10 
_________________________ 
Total:                          €230 
 
The writer will receive 40% of the cost of the course as sponsorship from her employer on completion. 
